Rural-Urban Disparities in Stage at Diagnosis and Treatment of Breast Cancer and the Influence of Geographical Level Characteristics by Ojinnaka, Chinedum Onyinyechi
RURAL-URBAN DISPARITIES IN STAGE AT DIAGNOSIS AND 
TREATMENT OF BREAST CANCER AND THE INFLUENCE OF 
GEOGRAPHICAL LEVEL CHARACTERISTICS 
A Dissertation 
by 
CHINEDUM ONYINYECHI OJINNAKA 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
Chair of Committee,  Jane N. Bolin 
Committee Members, Wen Luo 
Darcy McMaughan 
Marcia G. Ory 
Head of Department, Michael Morrisey 
May 2016 
Major Subject: Health Services Research 
Copyright 2016 Chinedum Onyinyechi Ojinnaka 
 ii 
 
ABSTRACT 
 
 This dissertation used multilevel regression methods to explore rural-urban 
disparities in stage at diagnosis of, and treatment of early-stage breast cancer among 
women diagnosed between 1995 and 2012, and whether other geographical 
characteristics explained these disparities. Trends in probability of late-stage diagnosis 
and treatment were explored. 
The Surveillance, Epidemiology and Ends Results data was used to explore rural-
urban disparities in stage at diagnosis of breast cancer and whether county poverty 
estimates explain these disparities. Compared to urban metropolitan residents, rural 
residents had higher odds of late-stage diagnosis (OR=1.09; CI= 1.03-1.15). County 
poverty explained the association between late stage diagnosis and urban non-
metropolitan (UNM) but not rural residence. Across all years, the probability of late-
stage diagnosis was highest for residents of rural high poverty areas.   
The Texas Cancer Registry (TCR) was utilized to explore rural-urban disparities 
in stage at diagnosis, and whether racial residential segregation, census tract (CT) 
poverty and travel distance to the nearest primary care provider (PCP) explained these 
disparities. Compared to urban metropolitan residents, residents of UNM residents had 
higher odds of late-stage diagnosis (OR=1.08; 95% CI=1.03 -1.13). Racial residential 
segregation, CT poverty and distance to the nearest PCP did not explain residential 
disparities. Residents of UNM high CT poverty areas had the highest probability of late-
stage diagnosis across all years.  
 iii 
 
The TCR was also used to explore rural-urban disparities in surgical treatment, 
type of surgery and adjuvant radiotherapy, and whether CT poverty and residential 
segregation explained these disparities. Compared to urban metropolitan residents, UNM 
residents had higher odds of having surgery (OR=1.39; 95%=1.27-1.53) and mastectomy 
(OR=1.18; 95%=1.12-1.25); UNM (OR=1.16; 95%=1.01-1.34) and rural (OR=1.66; 
95% CI=1.12-2.44) residents had higher odds of adjuvant radiotherapy. CT poverty and 
racial residential segregation explained the association between rural residence and 
surgical treatment. Across all years, residents of urban metropolitan high poverty CT had 
the lowest probability of being treated surgically and with adjuvant radiotherapy, and the 
highest probability of being treated using mastectomy.  
In conclusion, interventions aimed at reducing disparities in breast cancer 
diagnosis and treatment should be guided by both residence and area poverty levels.  
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1. INTRODUCTION: OVERVIEW   
 
Breast cancer is the most common type of cancer and the second leading cause of 
cancer deaths among women in the United States.
1
 In the year 2015, about 231,840 new 
cases of invasive breast cancer and 40,290 breast cancer deaths were projected to occur, 
accounting for 29% and 15% of cancer incidence and mortality respectively.
1
 In the state 
of Texas about 16,510 new breast cancer cases and 2,710 breast-cancer related deaths 
were expected to occur.
1
 Over 2.9 million women in the U.S were living with breast 
cancer in 2012.
2
  
Breast cancer also has an enormous impact on the economy. In 2010, compared 
to other  cancer types, direct cost of  breast cancer care was highest, accounting for $16.5 
billion (13%) of total cancer direct cost in the U.S, and it is projected that by 2020 the 
direct cost of breast cancer will be at least $21.37 billion.
3
 Increasing the prevalence of 
early-stage diagnosis therefore has potential for reducing the economic burden of breast 
cancer at the individual and the societal level. 
Although individual level characteristics such as race
4-7
 and insurance status
7,8
 
have been consistently reported to influence stage at diagnosis of breast cancer, 
individual factors do not completely explain variations in stage at diagnosis of breast 
cancer.
9
 Researchers have therefore sought to evaluate possible geographical 
characteristics that may be associated with late-stage breast cancer.  
Rural residence is one of the geographical factors that has been associated with 
late stage diagnosis;
10,11
 however, results have been inconsistent. A study reported a 
 2 
 
 
reversal, with urban residents having higher risk compared to rural residents
12
 while 
some studies report no difference between urban and rural residents.
13-15
 These 
inconsistencies make it necessary to continue to try to identify the associations between 
residence and late-stage breast cancer diagnosis, and how these associations may vary 
across various subpopulations. It is also important to identify possible geographical 
factors that could mediate residential disparities in stage at diagnosis of breast cancer. 
Residential segregation is defined as the physical separation of groups living in 
an area away from other groups and has been found to be associated with stage at 
diagnosis of breast cancer,
16,17
 it is however not clear whether residential segregation 
explains rural-urban disparities in stage at diagnosis of breast cancer. It is also not clear 
whether area poverty levels which have been found to be associated with late-stage 
breast cancer diagnosis
4,13,18,19 
explains rural-urban disparities in stage at diagnosis of 
breast cancer. Various studies have examined the association between proximity to 
diagnosing facilities and stage at diagnosis of breast cancer,
9,20
 but there is a gap in the 
literature about whether travel distance to the nearest primary care provider (PCP) is 
associated with stage at diagnosis of breast cancer. There is also a gap in literature about 
whether travel distance to nearest PCP explains rural-urban disparities. Since PCPs play 
a pivotal role in recommending breast cancer screening and explaining results to 
patients, it is important to identify whether access to PCPs is associated with or explains 
stage at diagnosis of breast cancer.  
In order to maintain the survival advantage of early-stage diagnosis, initiation of 
appropriate therapy following diagnosis is crucial. Early-stage breast cancer can be 
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treated surgically with mastectomy or breast conserving surgery.
21
 Whole breast 
irradiation is recommended following breast conserving surgery.
21
 Studies have found 
that rural residents have a higher likelihood of inadequate treatment following breast 
cancer diagnosis.
4,22-24
 Residents of areas that are racially segregated have also been 
found to have an increased likelihood of inadequate therapy.
25
 Haas and colleague also 
found that racial residential segregation mediated the association between race and 
adequate treatment.
25
 The findings by Haas et al indicate that there is a need to 
understand the influence of residential segregation on other reported breast cancer 
treatment disparities such as rural-urban residence. It is also important to identify 
whether area poverty level, which has been associated with inadequate breast cancer 
treatment 
4, 26, 27
 explains rural-urban disparities in treatment of breast cancer. 
This dissertation aims to bridge the gap in breast cancer research literature by 
identifying rural-urban disparities in stage-at diagnosis of breast cancer, and treatment of 
early-stage diagnosis using the three paper approach. Paper 1 utilized the Surveillance, 
Epidemiology, and Ends Results (SEER) data to provide national estimates of rural-
urban disparities in late-stage diagnosis among individuals diagnosed with breast cancer 
between 1995 and 2012, and explore whether county poverty level explained these 
disparities. Paper 2 utilized the Texas Cancer Registry (TCR) data to analyze rural-urban 
disparities in late-stage diagnosis among female residents of Texas diagnosed with breast 
cancer between 1995 and 2012, and whether census tract (CT) poverty, racial residential 
segregation and travel distance to the nearest primary health care provider explained 
these disparities. Finally, paper 3 utilized the Texas Cancer Registry data to analyze 
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disparities in treatment of breast cancer among residents of Texas diagnosed with early-
stage breast cancer between 1995 and 2012, and whether CT poverty and residential 
segregation explains residential disparities. Figure 1-1 gives an overview of the 
connection and progression of the three papers. 
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Figure 1-1.Overview and Progression of the Three Papers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dependent variable: stage at 
diagnosis (0=early; 1=late) 
Independent variables of 
interest: residence; county 
poverty estimates 
Paper 1 
Stage at Diagnosis of breast 
cancer using the Surveillance, 
Epidemiology and Ends Result 
Data, a national dataset 
Paper 2 
Stage at diagnosis using the 
Texas Cancer Registry 
Paper 3 
Treatment of early stage breast 
cancer using the Texas Cancer 
Registry 
Dependent Variable: Stage at 
diagnosis (0=early; 1=late) 
Independent variables of 
interest: residence; census tract 
poverty; residential segregation; 
travel distance to nearest 
primary care provider 
Dependent Variables: Receipt 
of surgical treatment; type of 
surgical treatment received; 
receipt of adjuvant radiotherapy 
Independent variables of 
interest: residence; census tract 
poverty; residential segregation 
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2. DOES COUNTY POVERTY LEVEL EXPLAIN RURAL-URBAN 
DISPARITIES IN LATE-STAGE DIAGNOSIS? 
2.1 Introduction 
 Early-stage diagnosis of breast cancer increases the chances of surviving breast 
cancer;
2
 survival rates for localized breast cancer are 98.6% compared to 24.3% if 
distant metastasis has occurred.
2
 Increasing the incidence of early-stage breast cancer 
diagnosis is crucial because breast cancer is the most common type of cancer and the 
second leading cause of cancer deaths among women in United States.
1
 In the year 2015, 
it was projected that about 231,840 new cases of invasive breast cancer and 40,290 
breast cancer deaths would occur, accounting for 29% and 15% of all cancer incidence 
and mortality respectively.
1
 Increasing the number of women diagnosed at an early-stage 
has potential for reducing mortality rates. 
Early-stage breast cancer diagnosis also reduces cost of treatment. Using 2000 
U.S dollar value, it was reported that the cost effectiveness ratio of treating stage I breast 
cancer was $1,960 compared to $70,380 for stage IV disease.
28
 Decreasing the 
prevalence of late-stage breast cancer diagnosis could therefore reduce the economic 
burden of breast cancer, improve compliance with treatment regimen due to cheaper 
treatment, and potentially, decrease mortality rates. Identifying factors that are 
associated with late-stage diagnosis and how trends in late-stage diagnosis have varied 
across socio-demographic groups could aid development of targeted interventions to 
increase rates of early-stage diagnosis among subpopulations. 
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In addition to individual level characteristics such as race
29, 22
  and ethnicity,
18
 
geographical-level characteristics such as residence and area poverty level have been 
found to influence stage-at diagnosis of breast cancer. Rural residence has been 
associated with significantly increased likelihood of late-stage diagnosis of breast 
cancer.
10
 However some studies have found no associations between rural residence and 
late-stage breast cancer diagnosis
13,14,22
 while another study found that urban residents 
had a higher likelihood of being diagnosed at a late-stage compared to rural residents.
12
 
Residents of high poverty areas have also been reported to have a higher likelihood of 
late-stage diagnosis compared to their counterparts.
13, 19
  
Since there are inconsistent research findings regarding the association between 
residence and stage at diagnosis of breast cancer, it is necessary to continue to explore 
rural-urban disparities in late-stage breast cancer diagnosis and how these disparities 
have varied over the years. It is also important to explore whether poverty levels explain 
the association between residence and late-stage diagnosis.  
This study aims to analyze: 
1. The independent association between rural/urban residence and county 
poverty level, and stage at diagnosis of breast cancer. 
2. Whether county poverty level explains rural-urban disparities in stage at 
diagnosis of breast cancer. 
3. The trends in probabilities of receiving a late-stage breast cancer 
diagnosis by residence and county poverty level for women diagnosed 
with breast cancer between 1995 and 2012. 
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This study will add to literature by identifying sub-populations that may be at 
higher risk for late-stage diagnosis. Any such findings will potentially guide more 
efficient and effective implementation of interventions. Identifying trends in late-stage 
diagnosis could also help in crafting and assessing policies and efforts to reduce these 
disparities. 
2.2 Conceptual Framework 
The conceptual frame work (Fig. 2-1) for this paper is based upon a modified 
version of the Andersen behavioral model.
30
 Three constructs are identified in the 
Anderson behavioral model namely: 1) primary determinants of health behavior, 2) 
health behavior and 3) health outcomes. This paper explores two of the three constructs: 
1) primary determinants of health behavior and 2) health outcomes. Primary 
determinants of health considered include: i) population characteristics such as age, race 
and ethnicity; and ii) external environmental factors such as rural versus urban residence, 
and county poverty level estimates. It is expected that these determinants of health will 
influence health outcome (stage at diagnosis). 
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Figure 2-1: Conceptual Model of Factors Influencing Stage at Diagnosis of Breast 
Cancer 
 
 
2.3  Methods  
The SEER data was the primary dataset that was used for this study. Using 
SEER*Stat software, individual data including residence and county poverty estimates 
were extracted.  The county poverty estimates used were from the 2000 census estimates 
of percent of individuals living below poverty in a given county. Inclusion criteria for 
our study were females 18 years and older diagnosed with breast cancer between 1995 
and 2012 who had only one primary tumor.  Final sample size was 576,022 individuals 
nested in 612 counties. This study was approved by the Texas A&M Institutional 
Review Board. 
Variables 
The dependent variable of interest was stage at diagnosis of breast cancer. In line 
with previous studies,
22,17,31
  the original stage at diagnosis variable was recoded as “0” 
early (in-situ and localized) and “1” late (regional or distant metastases). Independent 
variables of interest were residence and proportion of individuals living below poverty 
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level. Covariates were race, ethnicity, marital status, tumor grade, receptor status 
(estrogen and progesterone), year of diagnosis and age at diagnosis. Rural-urban 
classification was obtained from the SEER database and is based on the 2003 Rural 
Urban Continuum Codes (RUCC).
32 
The RUCC were condensed into three categories: 1) 
urban metropolitan (Counties in metro areas of 1 million population or more, counties in 
metro areas of 250,000 to 1 million population, counties in metro areas of fewer than 
250,000 population) 2) urban non-metropolitan (Urban population of 20,000 or more, 
adjacent to a metro area, Urban population of 20,000 or more, not adjacent to a metro 
area, Urban population of 2,500 to 19,999, adjacent to a metro area, Urban population of 
2,500 to 19,999, not adjacent to a metro area) and rural (Completely rural or less than 
2,500 urban population, adjacent to a metro area, Completely rural or less than 2,500 
urban population, not adjacent to a metro area). County poverty level were also 
classified into three categories into low poverty (<9.90% of residents living below 
poverty level), middle poverty (>9.90-19.90 living below poverty level) and high 
poverty (>19.90% of residents living below poverty level).
4
  
Analytic methods 
Descriptive analyses for select independent variables were conducted. Bivariate 
and multivariate multilevel logistic regression equations were estimated with individuals 
nested within counties. Three multivariate models were estimated: 1) rural/urban 
residence adjusting for the covariates without county poverty level 2) rural/urban 
residence and county poverty level adjusting for the covariates and 3) interaction 
between rural/urban residence and poverty levels adjusting for the covariates. 
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The general form of the three-level logistic regression was: 
Yij = γ00+ γ01Xij + γ02Cj + U0j  
Where Yij=log of late-stage probability divided by early stage probability for   
 person i in county j,  
γ00=overall intercept for the two level model 
i= indexes the individual level 
j= indexes the county level 
X= A vector of the individual level variables (race, ethnicity, tumor grade,   
estrogen receptor status, progesterone receptor status,  age, and year of 
diagnosis),  
C= A vector of the county level variables (residence, poverty estimates) 
Uj = error term at the county level 
Exponents of the coefficients (odds ratios) and 95% confidence interval are 
reported. Following multivariate model estimation, the predicted probabilities of late-
stage diagnosis by residence and county poverty level were estimated across all years. 
All statistical tests were two-sided, and findings were considered statistically significant 
at p < 0.05. All analyses were conducted using Stata 13.1.
33
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2.4  Results 
Table 2-1 shows the results of the descriptive analyses. About 82% of the study 
population were Whites, 10.37% were African Americans, 0.38% were American 
Indians/Alaskan Natives and 7.29% were Asians/Pacific Islanders. Non-Hispanics 
comprised 90.45% of the study population while 9.55% were Hispanics. Residents of 
urban metropolitan areas accounted for 90.45% of the study population, 9.53% were 
residents of urban non-metropolitan areas and 1.19% were residents of rural areas.  
About 54% of the study population were residents of middle poverty counties, residents 
of low poverty counties accounted for 39.50% of the study population while 7.03% of 
the study population were residents of high poverty counties. 
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Table 2-1: Descriptive Statistics of Individuals Diagnosed with Breast Cancer 
between 1995 and 2012: Surveillance, Epidemiology and Ends Results Data 
(n=576,022)  
Variable 
 
Freq. Percent 
Race 
  
 
White 472,089 81.96 
 
Black 59,717 10.37 
 
American Indian/Alaska Native 2,197 0.38 
 
Asian or Pacific Islander 42,019 7.29 
Ethnicity 
  
 
non-Hispanic 520,989 90.45 
 
Hispanic 55,033 9.55 
Residence 
  
 
Urban metropolitan area 514,277 89.28 
 
Urban non-metropolitan area 54,906 9.53 
 
Rural area 6,839 1.19 
Tumor grade 
  
 
low grade 327,302 56.82 
 
high grade 198,377 34.44 
 
Unknown 50,343 8.74 
Year of diagnosis 
  
 
1995 14,193 2.46 
 
1996 14,397 2.50 
 
1997 15,326 2.66 
 
1998 15,850 2.75 
 
1999 16,546 2.87 
 
2000 33,951 5.89 
 
2001 36,768 6.38 
 
2002 36,879 6.4 
 
2003 35,667 6.19 
 
2004 36,503 6.34 
 
2005 36,137 6.27 
 
2006 37,261 6.47 
 
2007 39,136 6.79 
 
2008 40,121 6.97 
 
2009 41,387 7.18 
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Table 2-1 Continued. 
Variable  Freq. Percent 
 
2010 40,689 7.06 
 
2011 42,094 7.31 
 
2012 43,117 7.49 
County Poverty level 
  
 
Low (<=9.90) 227,500 39.50 
 
Middle  (9.91-19.90) 308,040 53.48 
 
High (>=19.90) 40,482 7.03 
  
Mean Std. Dev. 
Age 
 
60.11 14.11 
 
Table 2-2 shows results from the bivariate and multivariate analyses. The 
bivariate model for residence did not achieve convergence and is therefore, not reported. 
On bivariate analysis (Model 1), compared to residents of low poverty counties, there 
was an increased likelihood of late-stage diagnosis among residents of middle 
(OR=1.08; 95% CI= 1.05-1.10) and high poverty counties (OR=1.22; 95% CI=1.18-
1.27).  
Controlling for the covariates (model 2), compared to urban metropolitan 
residents, urban non-metropolitan (OR=1.03; 95% CI=1.00-1.05) and rural residents 
(OR=1.15; 95% CI=1.08-1.21) had higher likelihood of receiving a late-stage diagnosis. 
Compared to those diagnosed in 1995, the baseline year, there was a statistically 
increased likelihood of late-stage diagnosis from 1998 to 2011. Compared to Whites, 
African Americans/Blacks (OR=1.30; 95% CI=1.27-1.32) and American 
Indians/Alaskan Natives (OR=1.20; 95% CI=1.10-1.31) had an increased likelihood of 
late stage diagnosis while Asians/pacific Islanders had a significantly decreased 
likelihood of late-stage diagnosis (OR=0.96; 95% CI=0.94-0.98). Hispanics had an 
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increased likelihood (OR=1.20; 95% CI=1.18-1.23) of late-stage diagnosis compared to 
non-Hispanics. 
Controlling for poverty (Table 2-2, model 3), rural residents continued to have a 
significantly increased likelihood of late-stage diagnosis (OR=1.09; CI= 1.03-1.15) 
compared to urban residents although the effect size decreased by 6%; the association 
between urban non-metropolitan residence and late stage diagnosis was no longer 
statistically significant. Compared to residents of low-poverty counties, there was an 
increased likelihood of late-stage diagnosis among residents of middle poverty 
(OR=1.07; 95% CI=1.05-1.09) and high poverty counties (OR=1.13; 95% CI=1.09-
1.17). On interacting residence and county poverty level, there was no significant 
association between the interaction term and stage at diagnosis of breast cancer (data not 
shown).  
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Table 2-2: Bivariate and Multivariate Analysis of Individuals Diagnosed with Breast Cancer between 1995 and 2012: 
Surveillance, Epidemiology and Ends Results Data (n=576,022)  
 Unadjusted Adjusted 
 Model 1 Model 2 Model 3 
 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Residence  
  Urban metropolitan area Ref. Ref. Ref. 
Urban non-metropolitan area     ---------- 1.03 (1.00-1.06) 0.98 (0.95-1.00) 
Rural area ---------- 1.15 (1.09-1.21) 1.09 (1.03-1.15) 
County poverty level  
  Low poverty (≤9.90% below FPL) Ref. Ref. Ref. 
Middle poverty (9.91% - 19.90% below FPL) 1.08 (1.05-1.10) ---------- 1.07 (1.05-1.09) 
High poverty (≥19.90% below FPL) 1.22 (1.18-1.27) ---------- 1.13 (1.09-1.17) 
Race  
  White  Ref. Ref. 
Black      1.30 (1.27-1.32) 1.29 (1.27-1.31) 
American Indian/Alaska Native      1.20 (1.10-1.31) 1.19 (1.09-1.30) 
Asian or Pacific Islander       0.96 (0.94-0.98) 0.97 (0.95-0.99) 
Marital status  
  Married  Ref. Ref. 
Single/Unmarried       1.19 (1.17-1.20) 1.19 (1.17-1.21) 
Divorced/Separated       1.15 (1.13-1.17) 1.15 (1.13-1.17) 
Widowed       1.24 (1.22-1.26) 1.24 (1.21-1.26) 
*Bold font indicates statistical significance 
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Table 2-2 Continued 
 Unadjusted Adjusted 
Ethnicity  
  Non-Hispanic   Ref. Ref. 
Hispanic       1.20 (1.18-1.23) 1.21 (1.19-1.23) 
Tumor grade  
  Low grade  Ref. Ref. 
High grade      2.03 (2.00-2.05)  2.03 (2.00-2.05) 
Unknown       1.82 (1.79-1.86) 1.82 (1.79-1.86) 
Estrogen receptor status  
  Positive  Ref. Ref. 
Negative      0.87 (0.85-0.88) 0.87 (0.85-0.88) 
Borderline      0.99 (0.87-1.13) 0.99 (0.87-1.12) 
Unknown       1.00 (0.96-1.05) 1.00 (0.95-1.05) 
Progesterone receptor status  
  Positive  Ref. Ref. 
Negative     1.09 (1.07-1.11) 1.09 (1.07-1.11) 
Borderline       1.01 (0.94-1.09) 1.01 (0.94-1.09) 
Unknown     0.98 (0.94-1.03) 0.99 (0.94-1.03) 
Age at diagnosis  0.99 (0.99-0.99) 0.99 (0.99-0.99) 
*Bold font indicates statistical significance 
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Table 2-2 Continued 
 Unadjusted Adjusted 
Year of diagnosis    
  Ref. Ref. 
1996  1.02 (0.97-1.07) 1.02 (0.97-1.07) 
1997  1.01 (0.96-1.06) 1.01 (0.96-1.06) 
1998  1.06 (1.01-1.12) 1.06 (1.01-1.12) 
1999  1.08 (1.03-1.14) 1.08 (1.03-1.14) 
2000  1.14 (1.10-1.19) 1.13 (1.09-1.18) 
2001  1.16 (1.11-1.21) 1.14 (1.10-1.19) 
2002  1.17 (1.12-1.22) 1.15 (1.11-1.20) 
2003  1.16 (1.11-1.21) 1.15 (1.10-1.19) 
2004  1.14 (1.09-1.19) 1.13 (1.08-1.17) 
2005  1.13 (1.08-1.18) 1.12 (1.07-1.16) 
2006  1.13 (1.08-1.18) 1.11 (1.07-1.16) 
2007  1.11 (1.06-1.16) 1.10 (1.05-1.14) 
2008  1.10 (1.06-1.15) 1.09 (1.05-1.14) 
2009  1.07 (1.02-1.11) 1.05 (1.01-1.10) 
2010  1.06 (1.02-1.11) 1.05 (1.01-1.09) 
2011  1.06 (1.01-1.10) 1.04 (1.00-1.09) 
2012  1.01 (0.97-1.05) 1.00 (0.96-1.04) 
*Bold font indicates statistical significance 
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Using estimates from the fully adjusted model, the predicted probabilities of late-
stage diagnosis showed that although there was a steady  decline in probability of late 
stage diagnosis between years 2002 and 2012 across all levels of residence and county 
poverty levels, disparities still exist (Fig. 2-2 -2-4). Rural residents and residents of high 
poverty counties (Fig. 2-2 and 2-3) consistently had the highest probabilities of late-
stage diagnosis across all years. Combining residence and county poverty levels (Fig. 2-
3),  across all years, the probability of late-stage diagnosis was highest for residents of 
rural high poverty areas while residents of urban non-metropolitan low poverty counties 
had the lowest probability of late-stage diagnosis.  Compared to residents of rural low 
poverty counties, residents of urban metropolitan high poverty and urban non-
metropolitan high poverty counties had a persistently higher probability of late-stage 
diagnosis (Fig. 2-4). Residents of rural low poverty counties had a higher probability of 
late-stage diagnosis compared to residents of urban metropolitan middle poverty, urban 
non-metropolitan middle poverty, urban metropolitan low poverty and urban non-
metropolitan low poverty counties respectively. 
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Figure 2-2: Trends in Predicted Probabilities of Late-Stage Breast Cancer 
Diagnosis by Residence: 1995-2012 
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Figure 2-3: Trends in Predicted Probabilities of Late-Stage Breast Cancer 
Diagnosis by County Poverty Level: 1995-2012 
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Figure 2-4: Trends in Predicted Probabilities of Late-Stage Breast Cancer 
Diagnosis by Residence and County Poverty Level: 1995-2012 
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2.5 Discussion 
In this study, the independent associations between late-stage breast cancer 
diagnoses, rural-urban residence and county poverty controlling for individual-level and 
tumor characteristics, and whether county poverty levels explained these residential 
disparities were explored. Trends in probability of late-stage diagnosis between 1995 
and 2012, by residence and county poverty levels were also explored. 
This study found that rural residents were at greater risk for late-stage diagnosis 
compared to their non-rural counterparts, a finding consistent with a previous meta-
analysis.
11
 County poverty level explained the association between late-stage diagnosis 
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and urban non-metropolitan residence; however, the association between late-stage 
diagnosis and rural residence persisted after we controlled for county poverty level.  This 
is in contrast to a previous study which reported that area poverty level explained the 
association between rural residence and late-stage diagnosis.
13
 The difference between 
this finding and the study by Henry and colleagues may be because county poverty 
levels were used in this study while census tract poverty levels were used in their study.   
This study is consistent with previous studies
13, 18, 19, 34
 which found that  county 
poverty level is an independent predictor of late-stage breast cancer diagnosis. In this 
study, the odds of late-stage breast cancer diagnosis increased with increasing county 
poverty level;  residents of middle poverty and high poverty counties had a 7% and 13% 
higher odds of late-stage diagnosis respectively, compared to residents of low poverty 
counties. These findings highlight the importance of implementing interventions to 
reduce late-stage diagnosis with a focus on county poverty level rather than just 
residence alone.  
On analyzing trends in the probability of receiving a late-stage diagnosis, a 
decline was seen starting from year 2002; however, disparities by residence and county 
poverty level persisted across all the years of analyses. Residents of rural high poverty 
areas consistently had the highest probability of late-stage diagnosis across all years 
while residents of urban non-metropolitan low poverty areas consistently had the lowest 
probability of late-stage diagnosis.  The persistence of these disparities across all years is 
indicative of the need for continued research aimed at identifying factors that are 
associated with disparities in breast cancer stage at diagnosis among groups at risk, as 
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well as developing strategies to mitigate the influence of such factors. These findings 
also suggest that although implementation of interventions to reduce late-stage breast 
cancer diagnosis among rural residents has potential for reducing disparities in late-stage 
breast cancer diagnosis, it is important to consider both residence and county poverty 
estimates when implementing such interventions.  For example, in this study, residents 
of urban metropolitan high poverty and urban non-metropolitan high poverty counties 
had a persistently higher probability of late-stage diagnosis compared to residents of 
rural low poverty counties. This therefore suggests that it might be a more efficient and 
effective use of resources to factor in both poverty estimates and residence when 
deciding areas where such interventions are most needed, especially if resources are 
scarce.  
2.6 Limitations and Strengths 
This study has some limitations. The SEER data is representative of only 28 
percent of the United States population; thus study findings may not be generalizable to 
the entire United States population. Another limitation is that the SEER data does not 
have lower level geographical information such as census tracts; therefore more detailed 
geographical analyses could not be performed. The data did not contain information on 
health care access measures such as availability of health care facilities, number of 
health care provider visits or routine breast cancer screening rates for age-eligible 
individuals. Thus, these factors which might mediate or moderate stage at diagnosis of 
breast cancer were not accounted for in the analyses.  
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Despite these limitations, the important contribution of this study to 
understanding disparities in stage at diagnosis of breast cancer is not diminished. Some 
significant strengths of this study include the use of a national dataset.  The large number 
of years included in the study also enhanced understanding of trends in late-stage 
diagnosis in the past decade. Another strength of this study is the use of multilevel 
modelling as it enabled accounting for variations across counties. The use of multiple 
years also provided insight into continued disparities in late-stage diagnosis between 
1995 and 2012, and how these disparities varied across sub-populations.  
In conclusion, one of the Healthy People 2020 objectives is to reduce the 
incidence of late-stage breast cancer diagnosis.
35
 Achieving this goal has potential for 
reducing the economic burden of breast cancer, as well as breast cancer-related 
mortality. Targeted interventions among populations with higher risk of late-stage 
diagnosis can play a pivotal role in achieving this important goal. The findings from this 
study suggest that stakeholders and policy makers should consider both residence and 
county poverty levels when deciding where interventions should be implemented. Such 
considerations will ensure that such programs or strategies are executed in areas with the 
highest needs.  It is also important to track trends in late-stage diagnosis as this will 
provide insights into the impact of interventions. 
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3. GEOGRAPHICAL DISPARITIES IN STAGE AT DIAGNOSIS OF
BREAST CANCER AMONG FEMALE RESIDENTS OF TEXAS 
3.1 Introduction 
One of the HealthyPeople2020 cancer objectives is to reduce the occurrence of 
late-stage female breast cancer.
35
 Reducing the occurrence of late-stage diagnosis is
crucial because early-stage diagnosis improves the chances of survival.
2
 (SEER n.d).
Early-stage diagnosis also reduces the economic burden of breast cancer at the national 
and individual level, because treatment is cheaper for early-stage tumors compared to 
late-stage tumors.
28 
Identification of factors that are associated with late-stage diagnosis
of breast cancer can guide education and screening interventions aimed at reducing the 
prevalence of late-stage breast cancer. 
Geographical level characteristics such as rural/urban residence,
9, 14, 22,
 census
tract poverty levels
4,13, 18, 19
  and racial or ethnic residential segregation
17,36, 
have been
associated with stage at diagnosis of breast cancer. The association between residence 
and stage at diagnosis has however been inconsistent. Studies have reported no 
significant association between residence and late-stage diagnosis
4, 13, 14, 20,  24
 while
McLafferty and colleagues reported that rural residents had a decreased likelihood of 
being diagnosed with late-stage breast cancer.
12
 A meta-analysis of 21 studies however,
found that rural residents had an increased likelihood of late-stage breast cancer 
diagnosis.
11
 Residential segregation –the physical separation of one racial/ethnic group
from another
16
 is another geographical level variable that has been associated with late-
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stage breast cancer diagnosis,
17
 although, results have also been inconsistent.
36
 These 
reported inconsistencies warrants further exploration of these factors.  
Various studies have explored the association between travel distance to the 
nearest mammography and breast cancer stage at diagnosis with inconsistent result.
9, 20
 
Studies have also explored the association between travel distance to the nearest health 
care provider and treatment choice following a breast cancer diagnosis.
37, 38
 There is 
however, a gap in the research literature about the association between travel distance to 
nearest PCP and stage at diagnosis of breast cancer. Since PCP recommendation is a 
predictor of breast cancer screening
39
 which in turn increases the chances of early-stage 
diagnosis, it is important to identify the influence of travel distance to nearest PCP on 
stage at diagnosis of breast cancer. 
This study aims to contribute towards bridging the gap in literature by analyzing: 
1. The independent association between rural/urban residence, census tract 
poverty levels, census tract residential segregation, travel distance to 
nearest PCP and stage at diagnosis of breast cancer. 
2. Whether census tract poverty level, residential segregation and travel 
distance to the nearest PCP explains rural-urban disparities in stage at 
diagnosis of breast cancer. 
3. The rural-urban trends in late-stage breast cancer diagnosis by census 
tract poverty 
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3.2 Conceptual Framework 
 The conceptual frame work (Fig. 3-1) for this paper is based upon the Andersen 
behavioral model.
30 
The original model identifies three constructs namely: 1) primary 
determinants of health behavior, 2) health behavior and 3) health outcomes. For the 
purpose of this study, a modified version of the model which identifies two of the three 
constructs (primary determinants of health and health outcomes) was used. In 
accordance with the Andersen behavioral model, three categories of determinants of 
health were explored, namely: i) population characteristics (age, marital status, race and 
ethnicity); ii) access to health care (travel distance to the nearest PCP); and iii) external 
environmental factors (rural versus urban residence, census tract poverty level estimates 
and residential segregation). It was expected that these determinants of health would 
influence the health outcome of interest which was stage at diagnosis. 
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Figure 3-1: Conceptual Model of Factors that Could Influence Stage at Diagnosis of 
Breast Cancer 
 
 
3.3 Methods 
The primary data set that was used for the analyses was the Texas Cancer 
Registry. Inclusion criteria were females ages 18 and older who were diagnosed with 
breast cancer between 1995 and 2012, and who had only one primary tumor.  Due to 
model non-convergence, the analyses were limited to individuals who identified their 
race as White or African American. Final sample size was 190,525 individuals nested in 
4358 census tracts which were nested in 254 counties.  
Variables 
The dependent variable of interest was stage at diagnosis. In line with previous 
studies,
 13, 17, 22
 the original stage at diagnosis variable was recoded as “0” early (in-situ 
and localized) and “1” late (regional or distant). The independent variables of interest 
were residence (urban metropolitan, urban non-metropolitan and rural), census tract 
poverty level (low “<=9.90% of the population living below FPL”, middle “9.91-19.90% 
of the population living below FPL”, high “>19.90% of the population living below 
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FPL), racial residential segregation and travel distance to nearest PCP (<=5 miles, >5-10 
miles, >10miles-15miles, >15 miles).  Covariates included race (White, Black), ethnicity 
(Hispanic, Non-Hispanic), tumor grade (Well differentiated, moderately differentiated, 
poorly differentiated, undifferentiated and unknown), age at diagnosis and year of 
diagnosis. 
Racial residential segregation was measured using the isolation index because the 
aim of this study was to measure the possibility of contact between an African American 
resident in an area to a White resident in the same area.
16, 17, 40
 The isolation index 
ranged from 0 (no segregation) to 1 (greatest segregation).  
Information on PCPs’ practice addresses was derived from the Texas Medical 
Board Physician database.  Using the Texas A&M University Department of Geography 
geocoding software
41
 addresses of the practices were assigned latitude and longitude 
coordinates. Only PCP whose licenses were active between January 1995 and December 
2012 and whose practices were located in Texas were included in the analyses. For the 
purpose of this study, physician specialties that were regarded as PCPs included family 
medicine, family practice, general practice, general preventive medicine, geriatric 
medicine, gynecology, internal medicine and preventive medicine. Final sample size of 
physicians was 21,606. Distance to the closest facility from a given patient’s residence 
was then derived using the network analyst of ArcGIS.
42
  
Analytic methods 
Descriptive statistics for select independent variables were conducted. Maps 
depicting spatial distribution of rural-urban designation and residential segregation and 
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CT poverty levels of the census tracts were generated. Since the dependent variable of 
interest was binary, logistic regression equations were estimated. Bivariate and 
multivariate multilevel logistic regression equations were estimated; individuals were 
nested within CTs, and CTs nested within counties. Bivariate models were estimated for 
residence, census tract poverty level, travel distance and residential segregation. 
However, due to model non-convergence only bivariate results for residence and 
residential segregation are reported. The final sample size consisted of 190,525 
individuals nested within 4,358 census tracts, nested within 254 counties. 
The general form of the three-level logistic regression was: 
Yijk = γ00+ γ01Xijk + γ02CTjk + γ03Ck + Ujk + Rk  
Where Yijk=log of late-stage probability divided by early stage probability for   
 person i in census tract j in county k,  
γ00=overall intercept for the two level model 
i= indexes the individual level 
j= indexes the CT level 
k= indexes the county level 
X= A vector of the individual level variables (race, ethnicity, tumor grade, age,  
and year of diagnosis),  
CT= A vector of the census tract level variables (poverty estimates, travel  
distance to nearest provider) 
C= A vector of the county level variables (residence, residential segregation) 
Ujk = error term at the census tract level 
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Rk = error term at the county level 
Exponents of the coefficients (odds ratios) and 95% confidence interval are reported. 
Two way interactions between residence and residential segregation, poverty level and 
travel distance to the nearest PCP were explored. Adjusted predicted probabilities of 
rural-urban trends in late-stage diagnosis by CT poverty levels were derived. All 
statistical tests were two-sided, and findings were considered statistically significant at p 
< 0.05. All analyses were conducted using Stata 13.1
33
 and ArcGIS.
42
  
3.4 Results 
Table 3-1 shows results of the descriptive analyses. Whites and African 
Americans comprised of 88.67% and 11.33% of the study population, respectively. 
About 83% of the study population where non-Hispanics while 16.68% were Hispanics. 
With regards to residence, residents of urban metropolitan areas accounted for 85.92% 
of the study population, 12.99% were residents of urban non-metropolitan areas and 
1.09% were residents of rural areas.  A majority of the study population were residents 
of low poverty census tracts (48.60%), residents of middle poverty census tracts 
accounted for 30.42% of the study population while 20.99% of the study population 
were residents of high poverty census tract.  
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Table 3-1 Descriptive Statistics of Texas Women Diagnosed with Breast Cancer 
between 1995 and 2012 (n=190,525) 
    Freq. Percent 
Race       
  White 168,948 88.67 
  African Americans/Black 21,577 11.33 
Ethnicity       
  Non-Hispanic 158,742 83.32 
  Hispanic 31,783 16.68 
Residence       
  Urban metro 163,708 85.92 
  Urban non-metro 24,740 12.99 
  Rural 2,077 1.09 
Poverty       
  low 92,588 48.60 
  middle 57,955 30.42 
  high 39,982 20.99 
Tumor grade       
  Well differentiated 28,163 14.78 
  Moderately differentiated 63,627 33.40 
  Poorly differentiated 63,825 33.50 
  Undifferentiated 3,372 1.77 
  Unknown 31,538 16.55 
Year of diagnosis       
  1995 7,643 4.01 
  1996 7,968 4.18 
  1997 8,613 4.52 
  1998 9,171 4.81 
  1999 9,582 5.03 
  2000 10,028 5.26 
  2001 10,234 5.37 
  2002 10,493 5.51 
  2003 10,393 5.45 
  2004 10,505 5.51 
  2005 10,943 5.74 
  2006 11,196 5.88 
  2007 11,950 6.27 
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Table 3-1: continued 
    Freq. Percent 
Year of diagnosis     
  2008 12,144 6.37 
  2009 12,811 6.72 
  2010 12,410 6.51 
  2011 12,223 6.42 
  2012 12,218 6.41 
 
 
Figure 3-2 shows the spatial distribution of urban metropolitan, urban non-
metropolitan and rural counties, isolation index of counties and census tract poverty 
estimates of our sample. There were no clear spatial patterns observed between the three 
variables. 
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Figure 3-2: Rural-urban county classification, county isolation index and census 
tract poverty estimates 
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Table 3-2 shows results of the bivariate and multivariate analyses. On bivariate 
analysis (Model 1), there was no statistically significant association between rural 
residence and late-stage diagnosis; residents of urban non-metropolitan areas had an 
increased likelihood (OR=1.09; 95% CI=1.05-1.14) of receiving a late-stage diagnosis 
compared to residents of urban residents.  There was a decreased likelihood of receiving 
a late-stage diagnosis with increasing (OR=0.86; 95% CI=0.78-0.96) racial residential 
segregation.  
Table 3-2 (Model 2) shows that controlling for the covariates, compared to urban 
metropolitan residents, urban non-metropolitan (OR=1.18; 95% CI=1.14-1.23) and rural 
residents (OR=1.14; 95% CI=1.03-1.27) had higher likelihood of receiving a late-stage 
diagnosis. African Americans had a higher likelihood (OR=1.46; 95% CI=1.41-1.50) of 
receiving a late-stage diagnosis compared to Whites. Hispanics had an increased 
likelihood (OR=1.39; 95% CI=1.35-1.43) of late-stage diagnosis compared to non-
Hispanics. Compared to those diagnosed in 1995, those diagnosed between 1997 and 
2012 had a significantly decreased likelihood of receiving a late-stage diagnosis.  
Controlling for poverty (Table 3-2, model 3), residents of urban non-
metropolitan areas continued to have a significantly increased likelihood of late-stage 
diagnosis (OR=1.11; CI= 1.07-1.16) compared to urban residents while the association 
between rural residence and stage at diagnosis was no longer significant. Compared to 
residents of low-poverty CTs, there was an increased likelihood of late-stage diagnosis 
among residents of middle poverty (OR=1.17; 95% CI=1.14-1.21) and high poverty CTs 
(OR=1.26; 95% CI=1.22-1.30).   
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Controlling for poverty, residential segregation and travel distance (Table 3-2, 
model 4), residents of urban non-metropolitan areas continued to have a significantly 
increased likelihood of late-stage diagnosis (OR=1.08; CI= 1.03-1.13) compared to 
urban residents while the association between rural residence and stage at diagnosis was 
no longer significant. Compared to residents of low-poverty CTs, there continued to be 
an increased likelihood of late-stage diagnosis among residents of middle poverty 
(OR=1.17; 95% CI=1.14-1.20) and high poverty CTs (OR=1.26; 95% CI=1.22-1.30).  
There was a decreased likelihood of late-stage diagnosis with increasing residential 
segregation (OR=0.67; 95% CI=0.60-0.76). There was no significant association 
between travel distance and late-stage diagnosis.
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Table 3-2: Bivariate and Multivariate Analysis of Stage at Diagnosis of Breast Cancer among Female Residents of 
Texas: 1995 and 2012 (n=190,525) 
 Unadjusted Adjusted 
 Model 1 Model 2 Model  3 Model  4 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Residence         
Urban metropolitan area Ref. Ref. Ref. Ref. 
Urban non-metropolitan area      1.09 (1.05-1.14) 1.18 (1.14-1.23) 1.11 (1.07-1.16) 1.08 (1.03-1.13) 
Rural area 0.98 (0.88-1.10)  1.14 (1.03-1.27) 1.08 (0.97-1.19) 1.02 (0.91-1.13) 
Isolation Index 0.86 (0.78-0.96)     0.67 (0.60-0.76) 
Census Tract Poverty Level         
Low poverty (≤9.90% below FPL)     Ref. Ref. 
Middle poverty (9.91% - 19.90% below FPL)     1.17 (1.14-1.21) 1.17 (1.14-1.20) 
High poverty (≥19.90% below FPL)     1.26 (1.22-1.30) 1.26 (1.22-1.30) 
Travel Distance to Nearest Primary Care Provider     
<5 miles     
 
Ref. 
> 5 miles & <=10 miles       1.03 (0.99-1.08) 
> 10 miles & <=15 miles       1.01 (0.94-1.09) 
>15 miles & <=20 miles       1.05 (0.94-1.18) 
>20 miles       1.10 (0.94-1.29) 
Race         
White   Ref. Ref. Ref. 
Black   1.46 (1.41-1.50) 1.36 (1.32-1.41) 1.37 (1.33-1.42) 
*Bold font indicates statistical significance 
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Table 3-2 Continued 
 Unadjusted Adjusted   
 Model 1 Model 2 Model  3 Model  4 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Ethnicity         
Non-Hispanic   Ref. Ref. Ref. 
Hispanic   1.39 (1.35-1.43) 1.32 (1.28-1.36) 1.32 (1.28-1.36) 
Tumor grade         
Well differentiated  Ref. Ref. Ref. 
Moderately differentiated   2.13 (2.06-2.21) 2.13 (2.06-2.21) 2.13 (2.06-2.21) 
Poorly differentiated   3.21 (3.10-3.32) 3.20 (3.09-3.32) 3.20 (3.09-3.31) 
Undifferentiated   2.28 (2.11-2.47) 2.27 (2.10-2.45) 2.27 (2.10-2.45) 
Unknown   1.77 (1.71-1.85) 1.77 (1.70-1.84) 1.77 (1.70-1.84) 
Age at Diagnosis   0.99 (0.99-0.99) 0.99 (0.99-0.99) 0.99 (0.99-0.99) 
*Bold font indicates statistical significance 
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Table 3-2 Continued 
 Unadjusted Adjusted   
 Model 1 Model 2 Model  3 Model  4 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Year of Diagnosis         
1995   Ref. Ref. Ref. 
1996   0.96 (0.90-1.03) 0.97 (0.90-1.03) 0.96 (0.90-1.03) 
1997   0.88 (0.82-0.94) 0.88 (0.83-0.94) 0.88 (0.83-0.94) 
1998   0.90 (0.84-0.96) 0.90 (0.84-0.96) 0.90 (0.84-0.96) 
1999   0.83 (0.78-0.89) 0.84 (0.78-0.89) 0.84 (0.78-0.89) 
2000   0.81 (0.76-0.87) 0.82 (0.77-0.87) 0.82 (0.77-0.87) 
2001   0.84 (0.79-0.90) 0.85 (0.80-0.91) 0.85 (0.80-0.90) 
2002   0.80 (0.75-0.85) 0.81 (0.76-0.86) 0.81 (0.76-0.86) 
2003   0.83 (0.78-0.88) 0.84 (0.79-0.89) 0.84 (0.79-0.89) 
2004   0.91 (0.86-0.97) 0.92 (0.87-0.98) 0.92 (0.87-0.98) 
2005   0.91 (0.86-0.97) 0.92 (0.87-0.98) 0.92 (0.87-0.98) 
2006   0.85 (0.80-0.91) 0.87 (0.82-0.92) 0.87 (0.81-0.92) 
2007   0.83 (0.78-0.88) 0.84 (0.79-0.89) 0.84 (0.79-0.89) 
2008   0.78 (0.73-0.83) 0.79 (0.75-0.84) 0.79 (0.74-0.84) 
2009   0.75 (0.70-0.79) 0.76 (0.71-0.81) 0.76 (0.71-0.81) 
2010   0.75 (0.70-0.79) 0.76 (0.71-0.81) 0.76 (0.71-0.81) 
2011   0.76 (0.71-0.80) 0.77 (0.72-0.82) 0.77 (0.72-0.82) 
2012   0.75 (0.70-0.79) 0.76 (0.71-0.81) 0.76 (0.71-0.81) 
*Bold font indicates statistical significance 
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Using estimates from the fully adjusted model, the predicted probabilities of late-
stage diagnosis were estimated. A decline in the probability of late stage diagnosis 
between 1995 and 2012 (data not shown) across all levels of residence and county 
poverty levels was seen. Figure 3-3 shows that across all years, the probability of late-
stage diagnosis was highest for urban non-metropolitan high poverty CT residents 
followed by rural high poverty CT residents, while it was lowest for urban metropolitan 
low poverty CT residents. Residents of UNM middle poverty and urban metropolitan 
high poverty CTs had the similar probability of late-stage diagnosis across all years. 
 
Figure 3-3: Trends in Predicted Probability of Late-Stage Diagnosis of Breast 
Cancer 
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3.5 Discussion 
In this study, CT poverty level and residential isolation index explained the 
association between rural residence and late-stage diagnosis but not the association 
between urban non-metropolitan residence and late-stage diagnosis. There was no 
statistically significant association between travel distance to the nearest PCP and stage 
at diagnosis of breast cancer.  
Residence 
There have been inconsistencies in the reported association between late-stage 
diagnosis and rural residence; however, a meta-analysis comprised of 21 studies and a 
sample size of 879,660 found that rural residents had a higher likelihood of being 
diagnosed with late-stage breast cancer compared to urban residents.
11
 In this study, 
there was no significant association between rural residence and late-stage diagnosis on 
bivariate analysis. After controlling for race, ethnicity, tumor grade, age and year of 
diagnoses, the association between rural residence and stage at diagnosis of breast cancer 
became statistically significant. Adjusting for CT poverty and residential segregation the 
association between rural residence and stage at diagnosis was no longer statistically 
significant but the association between stage and diagnosis and UNM residence 
remained statistically significant. This finding suggests that among our study population, 
CT poverty level and racial residential segregation explained disparities associated with 
rural residence but not UNM residence.  These results suggest that in the state of Texas, 
interventions to reduce disparities in stage at diagnosis of breast cancer are needed 
among residents of urban non-metropolitan. 
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 It has been suggested that increased cancer control interventions in rural areas 
are responsible for the lack of significant association between late-stage breast cancer 
diagnosis and rural residence.
13 
It might therefore be necessary to identify cancer control 
measures or interventions that have been resulted in decreased incidence of late-stage 
diagnosis in order to implement them in urban non-metropolitan areas in Texas 
Residential segregation 
In this study, residents of areas that had high racial residential segregation were 
found to have a decreased likelihood of late-stage diagnosis compared to residents of 
less segregated areas. In contrast to this study findings, a California study found no 
significant association between residential segregation and late-stage diagnosis; they 
however, reported that black women living in areas with low percentage of black women 
and white women living in areas of high percentage of black women had an increased 
odd of late-stage diagnosis.
43
 Another study comprised of individuals ages 65 and older 
reported that disparities in late-stage diagnosis between blacks and whites were less 
among blacks living in highly segregated areas compared to blacks living in low 
segregation areas.
44
 In agreement with our study, Mobley and colleagues found that 
residents of highly segregated areas had decreased odds of being diagnosed with late-
stage breast cancer.
36
 The finding of decreased association between late-stage diagnosis 
and increasing racial  residential segregation could be indicative of increased social 
support among such individuals
36
 ultimately leading to improved health-seeking 
behavior. A study that focused on residents of metropolitan areas found that blacks 
living in areas with high black residential segregation were more likely to be diagnosed 
 44 
 
 
with late-stage diagnosis.
17
 It is therefore possible that the association between racial 
residential segregation and late-stage breast cancer diagnosis is dependent on whether 
the area is metropolitan, non-metropolitan or rural; however, in this study interaction 
terms between residence and residential segregation were not significant.  
Poverty 
In this study, there was an independent association between increasing CT 
poverty and late-stage diagnosis. The fully adjusted model showed that residents of 
middle and high poverty CTS had a 17% and 26% higher odds of being diagnosed with 
late-stage breast cancer diagnosis, respectively. Previous studies have also reported an 
association between increased area poverty level and late-stage breast cancer 
diagnosis.
4,13,18, 19
 In contrast to this study however, Henry and colleagues found that CT 
poverty explained the association between rural residence and late-stage diagnosis.
13
 It 
has been suggested that increased likelihood of late-stage presentation among residents 
of high poverty areas could be attributed to inadequate access to health insurance, 
screening facilities and lack of information.
34
 In their study however, Hahn et al., did not 
find any significant association between screening using mammography, poverty and 
late-stage diagnosis.
45
 Another study that reported decreased odds of annual screening 
mammogram among residents of areas with 5-9.9% and 10% living below poverty level 
compared to residents of areas with 0-4.9% living in poverty
46
 did not find any 
significant association between poverty level and late-stage breast cancer diagnosis 
among the same population. There is therefore a need to continue to explore and identify 
factors that contribute to the observed increase in the risk of late-stage diagnosis among 
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residents of middle or high poverty areas. Variations in the association between area 
poverty and late-stage diagnosis have been previously reported across states
34
 
highlighting the importance of state-based studies. 
Travel distance 
There was no significant association between travel distance to the nearest PCP 
and late-stage diagnosis in this study. Other studies have also reported no significant 
association between proximity to diagnostic facilities and stage at diagnosis of breast 
cancer.
9,20
 These findings imply that proximity to a primary care practice or breast 
cancer diagnosing facility does not guarantee early-stage diagnosis.
9
 This finding also 
suggests that it might be more beneficial for interventions to reduce disparities in stage 
at diagnosis of breast cancer to focus on other access to health care measures that have 
been associated with late-stage disease such as lack of health insurance.
7,8,47
  
Trends 
In their study, Hausauer and colleagues reported that patterns of invasive breast 
cancer were similar for residents of urban and sub-urban counties but different for rural 
residents with rural residents having a higher incidence rate.
48
 Hausesur and colleagues 
did not find any difference in the incidence of invasive cancer incidence by county 
poverty level.
48
 This is in contrast to this study in which probability of late-stage 
diagnosis varied by residence and CT poverty levels, with residents of urban non-
metropolitan high poverty CTs having the highest probability across all years.  This 
difference could be because Hauser and colleagues were assessing incidence while this 
study was assessing probability of receiving a late-stage diagnosis. The difference could 
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also be because the study by Hausaeur et. al was a multistate study which used county 
level estimates while this study focused on only residents of Texas and used CT 
estimates. Hauser et al reported a decline in late-stage diagnosis;
48
 we also saw a decline 
in the predicted probabilities of late-stage diagnosis between 2004 and 2012. A study 
reported that although survival for breast cancer increased across all poverty levels 
between 1973 and 2007, mortality rates were still highest among residents of high 
poverty census tracts.
49
 In this study, analyzing trends in probability of late-stage 
diagnosis by residence and CT poverty level also highlighted the importance of 
considering these two factors when developing strategies to mitigate late-stage breast 
cancer diagnosis. 
3.6 Limitations and Strengths 
This study has some limitations. The TCR data is limited to the state of Texas, 
thus this study findings may not be generalizable to the entire United States population. 
Another limitation is that information on factors such as actual physician visitation or 
number of visitation which might further explain the association between healthcare 
provider availability and stage at diagnosis of breast cancer was not available and 
therefore, not included in the analyses. Information about insurance status was not 
available across all the years of interest; therefore this variable which has been 
previously reported to be associated with stage at diagnosis of breast cancer was not 
included in the analyses.  
This study also has a number of strengths. A unique strength of this study is that 
the data spanned across seventeen years allowing us to observe variations in late-stage 
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breast cancer diagnosis across the years of analyses. Another unique strength is the use 
of three-level models which allowed us to account for variations across CTs and 
counties. The use of CT also enabled analyses at a more granular geographical level. The 
ability to also use the Texas Medical Board physician database to establish proximity to 
PCPs also provided new insights in factors associated with disparities in stage at 
diagnosis. Ability to explore variations in late-stage diagnosis by residence and poverty 
levels also enabled identification of subpopulations at increased risk for late-stage 
diagnosis in the state of Texas. 
This study suggests that interventions to improve early stage diagnosis are 
needed most among residents of urban non-metropolitan high poverty CTs in Texas.  
 
 
 
 
 
 
 
 
 
 
48 
4. GEOGRAPHICAL DISPARITIES IN TREATMENT OF EARLY-
STAGE BREAST CANCER DIAGNOSIS AMONG FEMALE RESIDENTS OF 
TEXAS 
4.1 Introduction 
Treatment of breast cancer is dependent on the stage at which the tumor was 
diagnosed.
21
 Moreover, adequate and early treatment increases the chances of survival.
50
Surgical treatment using either breast conserving surgery or mastectomy is 
recommended for early stage tumors.
21
 Radiation following mastectomy is dependent on
whether tumor cells were found in the axillary lymph nodes; however, whole breast 
radiation therapy following breast conserving surgery, also known as adjuvant 
radiotherapy is recommended regardless of axillary lymph node involvement.
21
Randomized control trials have shown that individuals diagnosed with early stage 
tumors who received breast conserving surgery and radiation had equal chances of 
survival when compared to women who received mastectomy.
51,52
 There has also been
shown to be less than a five percent recurrence rate of breast cancer ten years post-
diagnosis among patients treated with breast conserving treatment and radiation 
therapy.
52
 Women who do not receive radiation therapy following breast conserving
surgery have been found to have about 14-15% higher recurrence rates;
53, 54
 Higher odds
of mortality (1.67-2.34) has also been reported among those who do not receive adjuvant 
radiotherapy.
50, 55, 56
Although researchers noted an initial decline in mastectomy rates after it was 
established that breast conserving surgery with adjuvant radiotherapy had comparable 
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survival rates with mastectomy, recent studies have reported a gradual increase in 
mastectomy rates.
57,56
 Although type of surgical treatment is usually individualized and 
dependent on various factors such as patient preference
57
 and tumor characteristics,
51
 
studies suggest that rural residents are more likely to be treated using mastectomy 
compared to their urban counterparts.
58
 Rural residents have also been reported to be less 
likely to receive adequate treatment following a diagnosis of breast cancer compared to 
urban residents
22,59
 This disparity in type of surgical treatment is worsened with 
increasing rurality.
58 
Rural residents have also been reported to be less likely to receive 
radiotherapy compared to urban residents.
4
  
There are inconsistencies about the association between poverty and receipt of 
surgical treatment. A Georgia study reported that residents of lower socioeconomic 
census tracts were less likely to receive surgical treatment following breast cancer 
diagnosis
4
 while a study comprised of residents of the Detroit area found no association 
between census tract poverty level and receipt of surgical treatment.
26
 Living in a high 
poverty census tract has also been associated with decreased likelihood of receiving 
breast conserving surgery and radiation therapy.
26, 4, 27
  
A study that comprised of only Medicare insured patients, reported that racial 
disparities in receipt of adequate treatment was mediated by residential segregation.
44
 
This highlights a need to explore whether racial residential segregation moderates other 
factors that have been associated with treatment of early-stage breast cancer. 
There is a gap in literature about the independent association between residence, 
CT poverty, residential segregation and treatment of early-stage breast cancer. Further 
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analyses are also needed to determine whether rural-urban disparities in breast cancer 
treatment are explained by CT poverty level and residential segregation. Understanding 
the interplay between these factors will provide clarification as to populations that have 
the greatest of need for interventions aimed at ensuring appropriate breast cancer 
treatment. 
The aim of this study was to analyze: 
1. The independent association between residence, CT poverty and 
residential segregation and surgical treatment, type of surgical 
treatment and receipt of radiation therapy following early stage 
diagnosis of breast cancer. 
2. Whether CT poverty and residential segregation explained rural-urban 
disparities in surgical treatment, type of surgical treatment and receipt 
of radiation therapy following early stage diagnosis of breast cancer. 
3.  Trends in probability of receiving surgical treatment, type of surgical 
treatment and receipt of radiation therapy among female residents of 
Texas diagnosed between 1995 and 2012.  
To our knowledge, this is the first study that sequentially explores disparities in 
cancer treatment across the treatment continuum controlling for residence, census tract 
poverty and residential segregation. 
4.2  Conceptual Framework 
The conceptual framework (Fig. 4-1) is a modified version of the model of 
access to cancer care.
60
 Our framework identifies two constructs that would influence 
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early-stage breast cancer treatment: 1) patient characteristics (race, ethnicity, age and 
tumor grade) and the individual context (rural/urban residence, CT poverty estimates and 
residential segregation). We expect that these constructs will influence receipt of 
treatment as well as type of treatment received. 
 
Figure 4-1. Conceptual Model of Access to Cancer Care 
 
 
4.3 Methods 
Study population 
The TCR was used for this study. The study population consisted of all females 
ages 18 and older diagnosed with early-stage breast cancer between 1995 and 2012 who 
had only one primary tumor. Due to small sample size and model non-convergence, 
analyses were limited to only those who were Whites or African Americans/Blacks. The 
study was approved by the Texas A&M University Institutional Review Board. 
Variables 
There were three dependent variables of interest: 1) whether a patient was treated 
surgically (0=No 1= Yes); 2) What type of surgical treatment was used (0=breast 
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conserving surgery 1=mastectomy) and 3) Whether a patient received radiation therapy 
following breast conserving surgery (0=No 1=Yes). The final sample size for receipt of 
surgical treatment was 124,821 individuals nested in 4,349 census tracts, the final 
sample size for type of surgical treatment was 94,390 individuals nested within 4,341 
CTs while the final sample size for receipt of radiotherapy following breast conserving 
surgery was 12,899 individuals nested in 3,633 CTs. The independent variables of 
interest were residence, census tract poverty level and racial residential segregation.  The 
census tract poverty level was derived from by the Texas Cancer Registry from the 
United States Decennial Census 2000 for those diagnosed between1995 and 2005 and 
Census 2010 for those diagnosed between 2006 and 2012. Covariates included race 
(White, Black), ethnicity (Hispanic, Non-Hispanic), age at diagnosis, year of diagnosis 
and tumor grade. Tumor grade was classified as low grade (well/moderately 
differentiated), high grade (poorly/undifferentiated) and unknown grade. 
Racial residential segregation was measured using the isolation index. The 
isolation index measures the possibility of contactor exposure between an African 
American resident in an area to a White resident in the same area
16,17,40
 The residential 
segregation index ranged from 0 (no segregation) to 1 (greatest segregation). 
Analytic methods 
Descriptive statistics for selected independent variables of interest were 
conducted. The dependent variables of interest were binary; therefore, logistic regression 
equations were estimated. Bivariate and multivariate two-level logistic regression 
equations were estimated; individuals were nested within CTs.  
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The general form of the three-level logistic regression was: 
Yij = γ00+ γ01Xij + γ02CTj + Uj  
Where Yij=log of probability surgical treatment/mastectomy/adjuvant 
radiotherapy divided by probability of probability no surgical treatment/BCS/no 
adjuvant radiotherapy for person i in census tract j,  
γ00=overall intercept for the two level model 
i= indexes the individual level 
j= indexes the CT level 
X= A vector of the individual level variables (race, ethnicity, age, and year of 
diagnosis),  
CT= A vector of the census tract level variables (residence, residential 
segregation, poverty estimates) 
Uj = error term at the census tract level 
Exponents of the coefficients (odds ratios) and 95% confidence interval are 
reported. Two way interactions between residence and residential segregation and 
poverty level were explored. Adjusted predicted probabilities of rural-urban trends in 
late-stage diagnosis by census tract poverty levels were derived. All statistical tests were 
two-sided, and findings were considered statistically significant at p < 0.05.  
Following multivariate regression analyses, Bayes estimates of the posterior 
means of random effects were estimated.
61
 In line with the cancer registry requirement, 
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to protect patient confidentiality, census tracts with less than 16 observations were not 
used to generate the maps. All analyses were conducted using Stata 13.1
33
 and ArcGIS.
42
  
4.4 Results 
Table 4-1 shows descriptive statistics for the study population. About 90% of the 
study population were whites and 9.96% were African Americans/Blacks. Hispanics 
comprised 15% of the population while non-Hispanics comprised 85%. Residents of 
urban metropolitan, urban non-metropolitan and rural areas comprised of 86.3%, 12.61% 
and 1.09% of the study population, respectively.  Residents of low poverty CTs 
comprised about 50.89% while residents of middle and high poverty CTs comprised 
29.87% and 19.24% of the study population respectively.  
 
Table 4-1 Descriptive Statistics of Texas Women Diagnosed with Early-Stage 
Breast Cancer between 1995 and 2012 (n=124,821) 
 
Freq. Percent 
Race 
  White 112,388 90.04 
Black 12,433 9.96 
Ethnicity 
  Non-Hispanic 106,093 85.00 
Hispanic 18,728 15.00 
Residence 
  Urban metro 107,721 86.3 
Urban non-metro 15,743 12.61 
Rural 1,357 1.09 
County Poverty level 
 low 63,521 50.89 
middle 37,280 29.87 
high 24,020 19.24 
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Table 4-1 Continued 
 Freq. Percent 
Tumor Grade 
  Low 65,145 52.19 
High 37,742 30.24 
Unknown 21,934 17.57 
Year of Diagnosis 
  1995 4,777 3.83 
1996 5,042 4.04 
1997 5,609 4.49 
1998 5,919 4.74 
1999 6,287 5.04 
2000 6,404 5.13 
2001 6,726 5.39 
2002 7,005 5.61 
2003 6,810 5.46 
2004 6,644 5.32 
2005 6,862 5.5 
2006 7,168 5.74 
2007 7,695 6.16 
2008 7,977 6.39 
2009 8,747 7.01 
2010 8,512 6.82 
2011 8,319 6.66 
2012 8,318 6.66 
 
 
Surgical treatment 
Table 4-2 shows results of the bivariate and multivariate analysis of receipt of 
surgical treatment. On bivariate analysis (model 1), compared to urban metropolitan 
residents, urban non-metropolitan (OR=1.69; 95% CI=1.55-1.85) and rural residents 
(OR=1.44; 95% CI=1.12-1.84) were more likely to receive surgical treatment. Compared 
to residents of low poverty CTs, residents of middle poverty CTs (OR=1.25; 95% 
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CI=1.18-1.34) were more likely to be surgically treatment; there was no statistically 
significant association between living in a high poverty area and receipt of surgical 
treatment. There was increased likelihood of not being treated surgically with increasing 
residential isolation (OR=0.36; 95% CI=0.31-0.43). 
Adjusting for residence and the control variables (race, ethnicity, tumor grade, 
age, year of diagnosis), urban non-metropolitan residents (OR=1.60; 95% CI=1.46-1.74) 
and rural residents (OR=1.29; 95% CI=1.00-1.65) continued to be significantly more 
likely to receive a surgical treatment compared to urban metropolitan residents. African 
Americans had a significantly decreased odds (OR=0.78; 95% CI=0.73-0.83) of 
receiving surgical treatment compared to Whites. Those whose tumor grades were 
unknown had a significantly decreased likelihood (OR=0.49; 95% CI=0.47-0.52) of 
receiving surgical treatment compared to those who had low grade tumors. Compared to 
those diagnosed in 1995, those who were diagnosed between 1996 and 2005 had 
statistically significant higher likelihood of being surgically treated while those 
diagnosed between 2006 and 2012 were significantly less likely to receive surgical 
treatment.  
Adjusting for residence, the control variables and CT poverty, urban non-
metropolitan residents (OR=1.57; 95% CI=1.44-1.72) continued to have a significantly 
higher likelihood of being treated surgically compared to urban metropolitan residents. 
The significant association between rural residence and surgical treatment was 
eliminated. Compared to residents of low poverty CTs, there was an increased likelihood 
of being treated surgically among residents of middle poverty CTs (OR=1.09; 95% 
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CI=1.02-1.16) while residents of high poverty CTs had decreased odds (OR=0.89; 95% 
CI=0.83-0.96) of being treated surgically. 
Adjusting for residence, the control variables and racial residential segregation, 
urban non-metropolitan residents (OR=1.41; 95% CI=1.29-1.54) continued to have a 
significantly higher likelihood of being treated surgically compared to urban 
metropolitan residents; the effect size of urban non-metropolitan residence decreased by 
19%, compared to the model adjusted for only the control variables. The significant 
association between rural residence and surgical treatment was eliminated. 
The fully adjusted model showed that urban non-metropolitan residents 
continued to have a higher likelihood (OR=1.39; 95% 1.27-1.53) of being surgically 
treated compared to urban metropolitan residents; rural residence was no longer 
significantly associated with receipt of surgical treatment. Residents of middle poverty 
CTs continued to be significantly more likely to receive surgical treatment (OR=1.08; 
95% CI=1.01-1.15) compared to residents of low poverty CTs; residents of high poverty 
CTs still had significantly lower odds of being surgically treated (OR=0.87; 95% 
CI=0.82-0.94). Increasing residential isolation continued to be associated with decreased 
likelihood of receiving a surgical treatment (OR=0.42; 95% CI=0.36-0.50). 
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Table 4-2: Bivariate and Multivariate Analysis of Surgical Treatment among Female Residents of Texas Diagnosed 
with Early-Stage Breast Cancer: 1995-2012 (n=124,821) 
 
 
Unadjusted Adjusted 
 Model 1 Model 2 Model 3 Model 4 Model 5 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Residence                                                  
Urban metropolitan 
area  Ref.  Ref.  Ref.  Ref.  Ref. 
Urban non-
metropolitan area     1.69 (1.55-1.85) 1.60 (1.46-1.74) 1.57 (1.44-1.72) 1.41 (1.29-1.54) 1.39 (1.27-1.53) 
Rural  area   1.44 (1.12-1.84) 1.29 (1.00-1.65) 1.26 (0.98-1.62) 1.09 (0.85-1.41) 1.08 (0.84-1.38) 
Census tract 
poverty level      
Low poverty (≤9.90% 
below FPL)  Ref.  Ref.  Ref.  Ref.  Ref. 
Middle poverty 
(9.91% - 19.90% 
below FPL) 1.25 (1.18-1.34)   1.09 (1.02-1.16)   1.08 (1.01-1.15) 
High poverty 
(≥19.90% below FPL) 0.98 (0.91-1.04)   0.89 (0.83-0.96)   0.87 (0.81-0.94) 
Isolation index   0.36 (0.31-0.43)      0.43 (0.37-0.51) 0.42 (0.36-0.50) 
Race           
White    Ref.  Ref.  Ref.  Ref. 
Black       0.78 (0.73-0.83) 0.80 (0.74-0.85) 0.83 (0.77-0.88) 0.85 (0.80-0.91) 
*Bold font indicates statistical significance 
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Table 4-2 Continued 
 Unadjusted Adjusted 
 Model 1 Model 2 Model 3 Model 4 Model 5 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Ethnicity                                                            
Non-Hispanic    Ref.  Ref.  Ref.  Ref. 
Hispanic       0.97 (0.91-1.03) 1.01 (0.94-1.07) 0.93 (0.87-0.98) 0.96 (0.90-1.03) 
Tumor grade                                             
Low     Ref.  Ref.  Ref.  Ref. 
High       0.99 (0.94-1.04) 0.99 (0.94-1.04) 0.98 (0.94-1.03) 0.98 (0.94-1.03) 
Unknown       0.49 (0.47-0.52) 0.49 (0.47-0.52) 0.49 (0.47-0.52) 0.49 (0.47-0.52) 
Age at diagnosis   1.01 (1.01-1.01) 1.01 (1.01-1.01) 1.01 (1.01-1.01) 1.01 (1.01-1.01) 
*Bold font indicates statistical significance 
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Table 4-2 Continued 
 Unadjusted Adjusted 
 Model 1 Model 2 Model 3 Model 4 Model 5 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Year of diagnosis                                             
1995    Ref.  Ref.  Ref.  Ref. 
1996   1.98 (1.66-2.37) 1.99 (1.66-2.37) 1.98 (1.66-2.36) 1.98 (1.66-2.36) 
1997   1.77 (1.50-2.09) 1.77 (1.50-2.09) 1.77 (1.49-2.09) 1.77 (1.50-2.09) 
1998   2.10 (1.76-2.49) 2.10 (1.76-2.49) 2.09 (1.75-2.48) 2.09 (1.75-2.48) 
1999   2.21 (1.86-2.63) 2.21 (1.86-2.64) 2.20 (1.85-2.63) 2.20 (1.85-2.63) 
2000   1.73 (1.47-2.03) 1.73 (1.47-2.03) 1.72 (1.46-2.02) 1.72 (1.46-2.02) 
2001   2.03 (1.72-2.40) 2.03 (1.72-2.40) 2.03 (1.72-2.40) 2.03 (1.71-2.39) 
2002   1.81 (1.54-2.12) 1.81 (1.54-2.12) 1.80 (1.53-2.11) 1.80 (1.53-2.11) 
2003   1.66 (1.42-1.95) 1.66 (1.41-1.94) 1.66 (1.41-1.94) 1.65 (1.41-1.94) 
2004   1.27 (1.09-1.47) 1.26 (1.09-1.47) 1.26 (1.08-1.47) 1.26 (1.08-1.46) 
2005   1.16 (1.00-1.35) 1.16 (1.00-1.34) 1.16 (1.00-1.34) 1.15 (0.99-1.33) 
2006   0.87 (0.75-1.00) 0.86 (0.75-0.99) 0.86 (0.75-0.99) 0.86 (0.75-0.98) 
2007   0.61 (0.54-0.70) 0.61 (0.53-0.69) 0.61 (0.53-0.69) 0.60 (0.53-0.69) 
2008   0.47 (0.42-0.54) 0.47 (0.42-0.54) 0.47 (0.41-0.53) 0.47 (0.41-0.53) 
2009   0.43 (0.38-0.49) 0.43 (0.38-0.49) 0.43 (0.38-0.49) 0.43 (0.38-0.48) 
2010   0.32 (0.28-0.36) 0.32 (0.28-0.36) 0.32 (0.28-0.36) 0.31 (0.28-0.36) 
2011   0.48 (0.43-0.55) 0.48 (0.43-0.55) 0.48 (0.42-0.54) 0.48 (0.42-0.54) 
2012   0.46 (0.40-0.52) 0.46 (0.40-0.52) 0.45 (0.40-0.51) 0.45 (0.40-0.51) 
*Bold font indicates statistical significance 
 
 61 
 
 
Figure 4-2 shows that among individuals diagnosed with early-stage breast 
cancer between 1995 and 2012, the lowest probability of being surgically treated was 
seen among those living in urban metropolitan, high poverty CT areas who were 
diagnosed in year 2010. Residents of urban non-metropolitan middle poverty census 
tracts had the highest probability of being surgically treated across all years of analyses. 
 
Figure 4-2: Trends in Predicted Probability of Surgical Treatment by Residence 
and Census Tract Poverty. 
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Type of surgical treatment 
Table 4-3 shows results of the bivariate and multivariate analysis of type of 
surgical treatment received (breast conserving surgery versus mastectomy). On bivariate 
analysis (unadjusted), compared to urban metropolitan residents, urban non-metropolitan 
(OR=1.35; 95% CI=1.28-1.41) were more likely to be treated with mastectomy; there 
was no significant association between rural residence and mastectomy. Compared to 
residents of low poverty CTs, there was increased likelihood of being treated with 
mastectomy among residents of middle poverty CTs (OR=1.25; 95% CI=1.18-1.34) and 
high poverty CTs (OR=1.37; 95% CI=1.31-1.43). There was decreased likelihood of 
being treated with mastectomy with increasing residential isolation (OR=0.62; 95% 
CI=0.56-0.68). 
Adjusting for residence and the control variables (race, ethnicity, tumor grade, 
age, year of diagnosis), urban non-metropolitan residents (OR=1.32; 95% CI=1.25-1.39) 
continued to be significantly more likely to be treated with mastectomy compared to 
urban metropolitan residents; there was no significant association between rural 
residence and type of surgical treatment. African Americans had significantly increased 
odds (OR=1.32; 95% CI=1.25-1.39) of being treated with mastectomy compared to 
Whites. There was increased likelihood of being treated with mastectomy among 
individuals who had high (OR=1.32; 95% CI=1.25-1.39) or unknown tumor grade 
(OR=1.24; 95% CI=1.19-1.30), compared to those who had low grade tumors. 
Compared to those diagnosed in 1995, those who were diagnosed between 1998 and 
2001 had statistically significant higher likelihood of being treated using mastectomy 
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while those diagnosed between 2003 and 2012 were significantly less likely to be treated 
with mastectomy.  
Adjusting for residence, the control variables and CT poverty, urban non-
metropolitan residents (OR=1.25; 95% CI=1.19-1.32) continued to have a significantly 
higher likelihood of being treated with mastectomy compared to urban metropolitan 
residents. There was no significant association between rural residence and type of 
surgical procedure used. Compared to residents of low poverty CTs, there was an 
increased likelihood of being treated with mastectomy among residents of middle 
poverty CTs (OR=1.11; 95% CI=1.07-1.16) and high poverty CTs (OR=1.19; 95% 
CI=1.13-1.25). 
Adjusting for residence, the control variables and racial residential segregation, 
urban non-metropolitan residents (OR=1.23; 95% CI=1.17-1.30) continued to have a 
significantly higher likelihood of being treated with mastectomy compared to urban 
metropolitan residents; the effect size of urban non-metropolitan residence decreased by 
9%, compared to the model adjusted for only the control variables. There was no 
significant association between rural residence and type of surgical treatment. 
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Table 4-3: Bivariate and Multivariate Analysis of Surgical Treatment using Breast Conserving Surgery versus 
Mastectomy among Female Residents of Texas Diagnosed with Early-Stage Breast Cancer: 1995-2012 (n=94,390) 
 
Unadjusted Adjusted 
Model 1 Model 2 Model 3 Model 4 Model 5 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
 Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
 Odds Ratio  
(95% CI) 
Residence                                                  
Urban metropolitan 
area  Ref.  Ref.  Ref.  Ref.  Ref. 
Urban non-
metropolitan area     1.35 (1.28-1.41) 1.32 (1.25-1.39) 1.25 (1.19-1.32) 1.23 (1.17-1.30) 1.18 (1.12-1.25) 
Rural area 1.15 (0.99-1.32) 1.10 (0.94-1.28) 1.04 (0.90-1.22) 1.01 (0.86-1.17) 0.96 (0.83-1.13) 
Census tract poverty 
level       
 
  
Low poverty  
(≤9.90% below FPL)   Ref.     Ref.                      Ref. 
Middle poverty  
(9.91% - 19.90% below 
FPL) 1.25 (1.21-1.30)   1.11 (1.07-1.16)   1.11 (1.06-1.15) 
High poverty  
(≥19.90% below FPL) 1.37 (1.31-1.43)   1.19 (1.13-1.25)   1.17 (1.12-1.23) 
Isolation index   0.62 (0.56-0.68)     0.63 (0.56-0.70) 0.64 (0.57-0.72) 
*Bold font indicates statistical significance 
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Table 4-3 Continued 
 
Unadjusted Adjusted 
Model 1 Model 2 Model 3 Model 4 Model 5 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
 Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
 Odds Ratio  
(95% CI) 
Race           
White    Ref.  Ref.  Ref.  Ref. 
Black       1.32 (1.25-1.39) 1.25 (1.19-1.32) 1.23 (1.17-1.30) 1.18 (1.12-1.25) 
Ethnicity                                           
Non-Hispanic    Ref.  Ref.  Ref.  Ref. 
Hispanic       1.32 (1.25-1.39) 1.25 (1.19-1.32) 1.23 (1.17-1.30) 1.18 (1.12-1.25) 
Tumor grade                                             
Low     Ref.  Ref.  Ref.  Ref. 
High       1.32 (1.25-1.39) 1.25 (1.19-1.32) 1.23 (1.17-1.30) 1.18 (1.12-1.25) 
Unknown       1.24 (1.19-1.30) 1.24 (1.19-1.29) 1.24 (1.19-1.29) 1.24 (1.19-1.29) 
Age at diagnosis   1.00 (1.00-1.00) 1.00 (1.00-1.00) 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
*Bold font indicates statistical significance 
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Table 4-3 Continued 
 
Unadjusted Adjusted 
Model 1 Model 2 Model 3 Model 4 Model 5 
  
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
 Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
 Odds Ratio  
(95% CI) 
Year of diagnosis                                             
1995    Ref.  Ref.  Ref.  Ref. 
1996   1.32 (1.25-1.39) 1.25 (1.19-1.32) 1.23 (1.17-1.30) 1.18 (1.12-1.25) 
1997   1.01 (0.91-1.12) 1.01 (0.91-1.12) 1.01 (0.91-1.12) 1.01 (0.91-1.12) 
1998   2.52 (2.22-2.85) 2.52 (2.22-2.86) 2.51 (2.21-2.85) 2.51 (2.21-2.85) 
1999   2.45 (2.16-2.77) 2.45 (2.16-2.78) 2.44 (2.16-2.77) 2.45 (2.16-2.77) 
2000   2.35 (2.07-2.66) 2.35 (2.08-2.67) 2.34 (2.06-2.65) 2.34 (2.07-2.65) 
2001   1.70 (1.52-1.91) 1.71 (1.53-1.92) 1.70 (1.51-1.90) 1.70 (1.52-1.91) 
2002   0.98 (0.88-1.08) 0.98 (0.89-1.09) 0.97 (0.88-1.08) 0.98 (0.88-1.09) 
2003   0.23 (0.21-0.25) 0.23 (0.21-0.25) 0.22 (0.21-0.25) 0.23 (0.21-0.25) 
2004   0.21 (0.19-0.23) 0.21 (0.19-0.23) 0.21 (0.19-0.23) 0.21 (0.19-0.23) 
2005   0.20 (0.18-0.22) 0.20 (0.18-0.22) 0.20 (0.18-0.22) 0.20 (0.18-0.22) 
2006   0.20 (0.18-0.22) 0.20 (0.18-0.22) 0.20 (0.18-0.22) 0.20 (0.18-0.22) 
2007   0.21 (0.19-0.23) 0.21 (0.19-0.23) 0.21 (0.19-0.23) 0.21 (0.19-0.23) 
2008   0.21 (0.19-0.23) 0.21 (0.19-0.23) 0.20 (0.19-0.22) 0.21 (0.19-0.23) 
2009   0.21 (0.19-0.23) 0.22 (0.20-0.24) 0.21 (0.19-0.23) 0.21 (0.20-0.23) 
2010   0.23 (0.21-0.25) 0.23 (0.21-0.25) 0.22 (0.20-0.24) 0.23 (0.21-0.25) 
2011   0.21 (0.20-0.24) 0.22 (0.20-0.24) 0.21 (0.20-0.23) 0.22 (0.20-0.24) 
2012   0.22 (0.20-0.24) 0.22 (0.20-0.24) 0.21 (0.20-0.23) 0.22 (0.20-0.24) 
*Bold font indicates statistical significance 
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The fully adjusted model showed that urban non-metropolitan residents 
continued to have a higher likelihood (OR=1.18; 95% 1.12-1.25) of being treated using 
mastectomy compared to urban metropolitan residents; the effect size of urban non-
metropolitan residence decreased by 14%, compared to the model adjusted for only the 
control variables. Rural residence was still not significantly associated with type of 
surgical treatment. Residents of middle poverty (OR=1.11; 95% CI=1.06-1.15) and high   
poverty (OR=1.17; 95% CI=1.12-1.23) CTs continued to be significantly more 
likely to be treated with mastectomy compared to residents of low poverty CTs. 
Increasing residential isolation continued to be associated with decreased likelihood of 
being treated using mastectomy (OR=0.64; 95% CI=0.57-0.72). 
Figure 4-3 shows a sharp decline in mastectomy between 2002 and 2003 across 
all levels of residence and census tract poverty. Residents of urban non-metropolitan 
high poverty census tracts had the highest probabilities of being treated using 
mastectomy across all years of analyses. 
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Figure 4-3: Trends in Predicted Probability of Treatment using Mastectomy by 
Residence and Census Tract Poverty 
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Radiation therapy 
Table 4-4 shows results of the bivariate and multivariate analysis of radiation 
therapy following breast conserving surgery. On bivariate analysis (unadjusted), 
compared to urban metropolitan residents, rural residents (OR=1.52; 95% CI=1.05-2.20) 
were more likely to receive adjuvant radiotherapy; there was no significant association 
between urban non-metropolitan residence and adjuvant radiotherapy treatment. 
Compared to residents of low poverty CTs, there was decreased likelihood of receiving 
radiotherapy among residents of high poverty CTs (OR=0.84; 95% CI=0.76-0.94); there 
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was no significant association between living in a middle poverty CT and receipt of 
radiation therapy. There was significantly increased likelihood of adjuvant radiotherapy 
treatment with increasing residential isolation (OR=1.43; 95% CI=1.12-1.81). 
Adjusting for residence and the control variables (race, ethnicity, tumor grade, 
age, year of diagnosis),  rural residents (OR=1.57; 95% CI=1.07-2.30) continued to be 
significantly more likely to be treated with radiotherapy compared to urban metropolitan 
residents; there was no significant association between urban non-metropolitan residence 
and treatment with adjuvant radiotherapy.  There was a significantly decreased 
likelihood of radiotherapy treatment among Hispanics (OR=0.72; 95% CI=0.65-0.80) 
compared to non-Hispanics. There was also a decreased likelihood of receiving 
radiotherapy among individuals who had high (OR=0.87; 95% CI=0.79-0.95) or 
unknown tumor grade (OR=0.61; 95% CI=0.54-0.68), compared to those who had low 
grade tumors. Compared to those diagnosed in 1995, those who were diagnosed between 
2010 and 2012 had statistically significant higher likelihood of being treated with 
radiotherapy.  
Adjusting for residence, the control variables and CT poverty, rural residents 
(OR=1.47; 95% CI=1.00-2.16) continued to have a significantly higher likelihood of 
being treated with radiotherapy compared to urban metropolitan residents. There was no 
significant association between urban non-metropolitan residence and receipt of adjuvant 
radiotherapy. Compared to residents of low poverty CTs, there was a significantly 
increased likelihood of radiotherapy among residents of middle poverty CTs (OR=1.15; 
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95% CI=1.04-1.27); the association between high poverty CT residence and radiation 
therapy was no longer significant. 
Adjusting for residence, the control variables and racial residential segregation, 
rural residents (OR=1.77; 95% CI=1.20-2.60) continued to have a significantly higher 
likelihood of being treated with radiotherapy compared to urban metropolitan residents. 
The association between urban non-metropolitan residence and receipt of adjuvant 
radiotherapy became significant (OR=1.22; 95% CI=1.07-1.40). There was increasing 
odds of receipt of radiotherapy with increasing racial residential segregation (OR=1.86; 
95% CI=1.43-2.43). 
The fully adjusted model showed that urban non-metropolitan residents 
(OR=1.16; 95% 1.01-1.34) and rural residents (OR=1.65; 95% CI= 1.12-2.44) continued 
to have a higher likelihood of being treated with radiation therapy compared to urban 
metropolitan residents. Residents of middle poverty (OR=1.15; 95% CI=1.06-1.15) 
continued to be significantly more likely to be treated with radiation therapy compared 
to residents of low poverty census tracts; there was no significant association between 
living in  a high poverty census tract and receipt of radiation therapy . Increasing 
residential isolation continued to be associated with increased likelihood of being treated 
using radiation therapy (OR=1.86; 95% CI=1.42-2.43).
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Table 4-4: Bivariate and Multivariate Analysis of Adjuvant Radiotherapy among Female Residents of Texas Diagnosed 
with Early-Stage Breast Cancer: 1995 and 2012 (n=12,899) 
 
 Unadjusted Adjusted 
 Model  1 Model  2 Model  3 Model  4 Model  5 
 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Residence                
Urban metropolitan 
area  Ref.   Ref.   Ref.   Ref.   Ref. 
Urban non-
metropolitan area     1.12 (0.98-1.27) 1.12 (0.99-1.28) 1.07 (0.94-1.23) 1.22 (1.07-1.40) 1.16 (1.01-1.34) 
Rural area 1.52 (1.05-2.20) 1.57 (1.07-2.30) 1.47 (1.00-2.16) 1.77 (1.20-2.60) 1.66 (1.12-2.44) 
Census tract poverty 
level           
Low poverty  
(≤9.90% below FPL)  Ref.      Ref. 
 
  Ref. 
Middle poverty  
(9.91% - 19.90% below 
FPL) 1.09 (0.99-1.19)   1.15 (1.04-1.27)   1.15 (1.05-1.27) 
High poverty  
(≥19.90% below FPL) 0.84 (0.76-0.94)   0.96 (0.85-1.09)   0.98 (0.87-1.10) 
Isolation index   1.43 (1.12-1.81)     1.86 (1.43-2.43) 1.86 (1.42-2.43) 
Race           
White     Ref.   Ref.   Ref.   Ref. 
Black       0.94 (0.83-1.07) 0.94 (0.83-1.07) 0.89 (0.78-1.01) 0.89 (0.78-1.01) 
*Bold font indicates statistical significance 
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Table 4-4 Continued 
 
 Unadjusted Adjusted 
 Model  1 Model  2 Model  3 Model  4 Model  5 
 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Ethnicity                          
Non-Hispanic     Ref.   Ref.   Ref.   Ref. 
Hispanic       0.72 (0.65-0.80) 0.73 (0.65-0.82) 0.75 (0.67-0.83) 0.75 (0.67-0.85) 
Tumor grade           
Low      Ref.   Ref.   Ref.   Ref. 
High       0.87 (0.79-0.95) 0.87 (0.79-0.95) 0.87 (0.80-0.95) 0.87 (0.79-0.95) 
Unknown       0.61 (0.54-0.68) 0.61 (0.54-0.68) 0.61 (0.54-0.68)  0.61 (0.54-0.68) 
Age at diagnosis   0.99 (0.99-1.00) 0.99 (0.99-1.00) 0.99 (0.99-1.00) 0.99 (0.99-1.00) 
*Bold font indicates statistical significance 
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Table 4-4 Continued 
 
 Unadjusted Adjusted 
 Model  1 Model  2 Model  3 Model  4 Model  5 
 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Odds Ratio  
(95% CI) 
Year of diagnosis           
1995     Ref.   Ref.   Ref.   Ref. 
1996   1.23 (0.96-1.57) 1.23 (0.96-1.58) 1.23 (0.96-1.58) 1.23 (0.96-1.58) 
1997   1.43 (1.03-1.99) 1.42 (1.02-1.98) 1.43 (1.03-1.98) 1.42 (1.02-1.97) 
1998   0.94 (0.33-2.66) 0.91 (0.32-2.58) 0.95 (0.34- 2.67) 0.92 (0.33-2.59) 
1999   1.66 (0.49-5.60) 1.65 (0.49-5.57) 1.65 (0.49-5.58) 1.64 (0.48-5.55) 
2000   3.11 (0.78-12.41)  3.14 (0.79-12.57) 3.22 (0.80-12.87) 3.26 (0.81-13.05) 
2001   6.30 (1.67-23.74) 6.28 (1.66-23.70) 6.39 (1.69-24.09) 6.37 (1.68-24.06) 
2002   0.59 (0.20-1.78) 0.59 (0.20-1.75) 0.61 (0.20-1.83) 0.60 (0.20-1.81) 
2003   0.60 (0.34-1.07) 0.61 (0.34-1.08) 0.59 (0.33-1.05) 0.60 (0.34-1.06) 
2004   4.75 (2.36-9.56) 4.80 (2.38-9.68) 4.85 (2.41-9.77) 4.90 (2.43-9.88) 
2005   5.41 (2.63-11.15) 5.44 (2.64-11.21) 5.42 (2.63-11.17) 5.45 (2.65-11.23) 
2006   3.31 (1.70-6.45) 3.33 (1.71-6.49) 3.34 (1.71-6.52) 3.36 (1.72-6.55) 
2007   7.19 (3.83-13.51) 7.18 (3.82-13.48) 7.29 (3.88-13.71) 7.29 (3.88-13.70) 
2008   5.19 (3.05-8.83) 5.25 (3.09-v) 5.27 (3.10-8.97) 5.34 (3.14-9.09) 
2009   7.76 (5.79-10.41) 7.81 (5.82-10.48) 7.96 (5.93-10.67) 8.01 (5.97-10.75) 
2010   3.33 (2.74-4.05) 3.35 (2.76-4.07) 3.38 (2.78-4.11) 3.40 (2.79-4.13) 
2011   3.82 (3.15-4.63) 3.83 (3.16-4.65) 3.89 (3.21-4.72) 3.91 (3.22-4.74) 
2012   4.21 (3.46-5.11) 4.23 (3.48-5.13) 4.31 (3.54-5.23) 4.33 (3.56-5.26) 
*Bold font indicates statistical significance
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Figure 4-4 shows fluctuations in receipt of radiotherapy following BCS with a 
steep decline in seen in 2002 and a steep increase in 2004. Residents of rural middle 
poverty census tracts had the highest probability of receiving adjuvant radiotherapy 
across all years of analyses while residents of urban metropolitan low and high poverty 
counties had the lowest predicted probability of receiving radiotherapy across all years 
of analyses. 
 
Figure 4-4: Trends in Predicted Probability of Treatment using Adjuvant 
Radiotherapy 
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Figure 4-5 shows results of the Bayes estimates of the random intercepts of the 
models for surgical treatment, type of surgical treatment and receipt of adjuvant 
radiotherapy. Darker colors indicate census tracts with decreased likelihood of surgical 
treatment, breast conserving surgery or adjuvant radiotherapy. 
 
Figure 4-5: Census Tract Bayesian Estimates of Slopes of Surgical Treatment, 
Mastectomy and Radiotherapy post-mastectomy after Early-Stage Breast Cancer 
Diagnosis. 
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4.5 Discussion 
In this study, residential disparities in treatment of breast cancer among women 
diagnosed with early stage disease, and whether census tract poverty level and 
residential segregation explained these disparities were analyzed.  Trends in probability 
of treatment between 1995 and 2012 were also analyzed. 
Receipt of surgical treatment 
With regards to receiving surgical treatment (mastectomy or breast conserving 
surgery) versus not receiving surgical treatment, there was a reversal in rural-urban 
disparities on bivariate analysis. Rural and urban non-metropolitan residents had an 
increased likelihood of receiving surgical treatment compared to urban metropolitan 
residents; this persisted after controlling for race, ethnicity, tumor grade and year of 
diagnosis. We however, found that census tract poverty levels and residential 
segregation eliminated the significant association between rural residence and receiving 
a surgical treatment but not the association between urban non-metropolitan residence 
and receipt of surgical treatment. A Georgia study also found no significant association 
between rural residence and receipt of surgical treatment.
22
 In another study however, 
Markossian and colleagues found a significantly increased association between rural 
residence and receipt of surgical treatment
4 
while a South Carolina study found that rural 
patients had a decreased likelihood of being surgically treated compared to the urban 
patients.
62
 In the present study, residents of high poverty CTs were less likely to receive 
surgical treatment compared to residents of low poverty CTs. Interestingly, residents of 
middle poverty census tracts had an eight percent higher likelihood of being surgically 
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treated compared to residents of low poverty census tracts. Markossian and colleagues 
also found that women who were living in high poverty CTs were less likely to receive 
surgical treatment.
4
 Increasing levels of residential segregation was associated with a 
58% decreased odds of receiving surgical treatment.  
Type of surgical treatment 
There was no significant association between rural residence and type of surgical 
treatment received while urban non-metropolitan residents had an 18% higher likelihood 
of being treated using mastectomy compared to urban metropolitan residents. This 
finding is in contrast to a Georgia study which found that rural residents were 
significantly more likely to be treated using mastectomy.
22
 A study that utilized the 
Surveillance Epidemiology and Ends Result database, also found that rural women had 
an increased likelihood of receiving mastectomy compared to urban residents.
63
 A 
Kentucky study also reported that rural residents were more likely to be treated using 
mastectomy; they also found that although the use of mastectomy decreased between 
1998 and 2005, it increased back in 2007.
56
 Another Kentucky study found that rural 
residents were more likely to receive mastectomy compared to their urban 
counterparts.
64
 An Australian study also reported that residents of rural areas had an 
increased likelihood of receiving mastectomy compared to urban residents.
65
  
Census tract poverty levels and residential segregation did not explain the 
association between urban non-metropolitan residence and treatment using mastectomy. 
Residents of residentially segregated areas had a significantly decreased likelihood of 
being treated using mastectomy. A study that comprised of only Medicare patients 
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reported that residents of residentially segregated areas had a decreased likelihood of 
receiving adequate surgical treatment.
44
 The increased likelihood of being treated using 
BCS among residents of residentially segregated areas in spite of the reduced likelihood 
of surgical treatment could imply that although residents of such areas could face 
barriers to surgically treatment, these barriers do not appear to influence type of surgical 
treatment used.  
There was an increase in the likelihood of being treated using mastectomy with 
increasing CT poverty levels. In their study, Gorey and colleagues also found that 
Californian residents of impoverished neighborhoods were less likely to receive breast 
conserving surgery compared to residents of affluent poverty although they found no 
such associations among Canadians.
66 
A study comprised of only Medicare patients, 
reported that residents of low poverty areas and urban areas were more likely to receive 
BCS compared to their counterparts.
67
  
Radiation therapy 
With regards to receipt of adjuvant radiation therapy, there was also a reversal in 
rural-urban disparities among this study population. Rural and urban non-metropolitan 
residents had a 16% and 65% higher likelihood of receiving radiotherapy treatment 
respectively, compared to urban metropolitan residents. This finding is in contrast to the 
studies by Markossian and colleagues which found that rural Georgia residents 
diagnosed with breast cancer had decreased odds of receiving radiation therapy.
4,22
 
Another study consisting of residents of Sacramento and 13 counties around Sacramento 
reported that rural residents and residents of areas close to metropolitan areas had a 
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decreased likelihood of receiving radiation therapy following lumpectomy; however, 
their study was not restricted to only patients who had early-stage tumors.
68
 A study 
which utilized the SEER data and focused on women diagnosed with breast cancer 
between 2000 and 2009 also found that rural residents were less likely to receive 
radiotherapy compared to urban residents.
69
 These differences in findings could be 
because these studies included patients with all stages of breast cancer while this study 
was limited to patients who had early-stage breast cancer. However, a Kentucky study of 
patients diagnosed with early-stage breast cancer reported that rural residents had a 
decreased likelihood of receiving radiotherapy after breast conserving surgery.
56
 Another 
Kentucky study which included only patients diagnosed with early-stage breast cancer 
also found that rural residents were less likely to receive radiation therapy after BCS.
64
 
Women who were treated in rural centers have also been reported to be less likely to 
receive radiotherapy following BCS.
70
 The difference between our findings and the 
findings by Dragun et al. and Freeman et al. is highlights variations in disparities that 
could exist across states, and the importance of state-based studies. It is also possible 
that rural residents who opt to be treated with BCS do so because they have the means to 
pay for radiotherapy, thus, our study results. 
Census tract poverty and residential segregation did not explain the association 
between receipt of radiation therapy and rural residence; however the association 
between urban non-metropolitan residence and receipt of radiation therapy became 
significant after the two variables were included in the model.  Increasing residential 
segregation was associated with increased likelihood of receiving radiation therapy. 
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Residents of middle poverty census tracts had 15% higher likelihood of receiving 
radiation therapy compared to residents of low poverty CTs; there was no significant 
association between living in a high poverty area and receiving radiation therapy. In 
contrast to these findings, Markossian and colleagues reported that residents of middle 
and high poverty CTs were less likely to receive radiotherapy compared to residents of 
low poverty CTs.
4
  
Trends in probability of receipt of surgical treatment, mastectomy and 
radiotherapy 
There was a gradual decline in receipt of surgical treatment between 2001 and 
2010. However, the lowest probability of receiving surgical treatment found among 
residents of urban metropolitan high poverty census tracts was 0.79. A steep decline in 
mastectomy rates was observed among those diagnosed with early-stage breast cancer 
between 2002 and 2003 across all levels of residence and CT poverty. It is possible that 
this decline be as a result of increased awareness of equal survival rates for mastectomy 
and BCS with adjuvant radiotherapy. In contrast to these findings, a study based upon 
data from the Mofitt cancer center that focused on patients diagnosed with breast cancer 
between 1994 and 2007 reported a gradual increase in mastectomy across a years of 
studies.
57
 A Kentucky study also found that although the use of mastectomy decreased 
between 1998 and 2005, it increased back in 2007.
56
 In contrast to the studies by 
Mcguire and Dragun, in the current study, probability of treated using mastectomy has 
plateaued since 2002. There were constant fluctuations in receipt of adjuvant 
 81 
 
 
radiotherapy could be an indication for a need to increase access to patients and 
implement interventions to ensure that providers adhere to best practices.  
4.6 Limitations and Strengths 
This study has some limitations. First, the TCR data only covers the state of 
Texas, thus study findings may not be generalizable to the entire United States 
population. This study was also limited to those who had early-stage diagnosis, thus the 
findings may not be generalized to patients who are diagnosed with late-stage breast 
cancer. Analyses were limited to individuals who identified their race as White or 
African American/Blacks and thus, study findings may not be generalizable to other 
racial groups. Information on patient preference of type of surgical treatment which 
could influence treatment options was not available and therefore not included in the 
analyses. Information on health insurance was also not available across all years of 
analyses therefore we were unable to control the association between health coverage 
and stage at diagnosis. The results of the radiation therapy analyses should also be 
interpreted with caution because of the smaller sample size and the large confidence 
interval of some of the estimates.  
In spite of these limitations, this study has several strengths. First to prior to this 
study, to the best of our knowledge, only one study had previously  explored the 
association between residential segregation and breast cancer treatment, and the study 
comprised of only Medicare patients while our study comprised of all adults. The use of 
multilevel models also allowed us to account for variations across CTs. The large 
number of years also provided a clearer picture about how treatment patterns have varied 
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across the years of our analyses. Our use of GIS also enabled identification of particular 
census tracts that have a higher probability of inadequate treatment which in turn could 
provide guidance for stake holders in such CTs. 
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5. SUMMARY AND CONCLUSION 
5.1 Summary 
In this study, between the national and state cohorts, there were variations in 
residential disparities in stage at diagnosis of breast cancer. Among the national cohort, 
rural and urban non-metropolitan residents were more likely to receive a late-stage 
diagnosis compared to those who lived in urban metropolitan areas; county poverty level 
explained the association between UNM residence and late-stage diagnosis but not the 
association between rural residence and late-stage breast cancer. Women who lived in 
rural areas with high poverty levels were the most likely to have late-stage breast cancer 
across all years. 
Among residents of the state of Texas, women who lived in urban non-
metropolitan areas were more likely to receive a late-stage diagnosis compared to urban 
metropolitan residents. There was no association between rural residence and late-stage 
diagnosis. Increasing levels of residential segregation levels was associated with 
decreased likelihood of late-stage diagnosis. There was no significant association 
between travel distance to nearest health care provider and stage at diagnosis of breast 
cancer. Women who lived in census tracts with high poverty areas were more likely to 
have late-stage breast cancer compared to women who lived in low poverty census 
tracts. Women who lived in UNM high census tract poverty areas were the most likely to 
have late-stage breast cancer across all years. 
Acceptable treatment of early-stage breast cancer includes mastectomy or breast 
conserving surgery accompanied by radiotherapy. Treatment using breast conserving 
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surgery with adjuvant radiotherapy has been shown to have comparable survival benefits 
with treatment using mastectomy.
51
 This advantage is lost if BCS is not accompanied by 
radiotherapy.
50, 55, 56
  
The third analysis showed that residents of UNM and rural residents were more 
likely to receive any surgical treatment compared to urban metropolitan residents. 
Census tract poverty and residential segregation, explained the association between rural 
residence and surgical treatment but not the relationship between urban non-
metropolitan residence and surgical treatment of breast cancer. Residents of urban non-
metropolitan were more likely to be treated with mastectomy; there was no significant 
association between rural residence and type of surgical treatment. Rural residents were 
more likely to be treated with adjuvant radiotherapy. There was no association between 
UNM residence and stage at diagnosis of breast cancer. Across all years, residents of 
urban metropolitan high poverty CTs had the lowest probability of being treated 
surgically and the lowest probability of receiving radiotherapy after breast conserving 
surgery. Residents of UNM high poverty CTs had the highest probability of being 
treated using mastectomy across all years. 
5.2 Policy and Practice Implications 
The findings from this study have important policy and practice implications. 
The results reinforce the need to monitor trends in late-stage diagnosis nationally and the 
state level, as this could provide insights into gains that have been made with regards to 
reduction of disparities in late-stage diagnosis of breast cancer.   The results also 
highlight the need for state-based interventions or modification of national policies and 
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interventions in order to ensure that state needs are being met. For example, based upon 
results from the analyses of the national cohort, it would be logical to develop 
interventions or programs that focus on rural residents; however, the Texas–based 
analyses showed that rural residents were not more likely to have late-stage diagnosis. 
Associations between area poverty and late-stage diagnosis has also been found to vary 
across states.
34
  
The persistent association between late-stage diagnosis and area poverty is an 
indication that concerted efforts are needed to identify factors or barriers that contribute 
to these disparities among residents of middle and high poverty areas. It is also necessary 
to develop and implement interventions targeting such factors or barriers among 
residents of poor communities.  
The absence of statistically significant association between travel distance to the 
nearest PCP and stage at diagnosis of breast cancer could be good news for poorer 
communities that have fewer PCPs or primary care facilities due to financial constraints. 
This lack of association suggests that could be indicative of a need to explore other 
access to care measures such as patient navigation, care coordination, insurance status, 
and lack of knowledge, in order to identify the influence they have on breast cancer 
disparities, and develop interventions accordingly.  
The inadequate treatment found among residents of highly racially segregated 
and urban metropolitan areas could also provide guidance to stakeholders working to 
eliminate early-stage breast cancer treatment disparities. This finding could be an 
indication that outreach programs and educational efforts are needed to raise awareness 
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of disparities in breast cancer treatment among residents and health care providers in 
urban metropolitan and racially segregated areas. Strategies to increase access to 
adequate treatment should also be explored. It is also important to identify the reasons 
for the increased likelihood of mastectomy found among residents of UNM residents. 
This will provide insights about whether the higher odds of mastectomy are as result of 
patients’ preference, or other factors such as inadequate knowledge about the 
comparable outcomes between mastectomy and BCS combined with radiotherapy or 
inadequate access. 
The ability to identify specific groups that have higher risks of late-stage 
diagnosis and inadequate treatment, by levels of residence and area poverty level is also 
important because resources for interventions that aim to reduce disparities are usually 
limited. Identifying sub-groups that have such high risks could therefore ensure that such 
interventions are implemented in areas that have the most need. For example, this study 
shows that residents of urban non-metropolitan areas in Texas have the highest need for 
interventions aimed at increasing early-stage breast cancer diagnosis while residents of 
urban metropolitan high poverty census tracts have the most need for interventions to 
ensure adequate treatment of breast cancer.  
5.3 Conclusion 
In order to achieve the HealthyPeople 2020 objectives of reducing the incidence 
of late-stage breast cancer as well as mortality rates, it is important to consider 
geographical characteristics when developing and implementing interventions aimed at 
reducing disparities in stage at diagnosis and treatment of breast cancer.  
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